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Abstract 
Calcium (Ca2+) levels in neurons are strictly regulated and Ca2+ 
dysregulation has previously been linked to neuronal cell death. In the 
mammalian retina, Ca2+ dysregulation may be connected to both cone 
and rod photoreceptor cell death (e.g. Arango-Gonzalez et al., 2014, 
Kulkarni et al., 2016). The interpretation of this research has, 
however, been hampered by spatial inhomogeneity of retinal 
degenerative events, depending on the model used.  
Here we examined the spatio-temporal activation patterns of the Ca2+-
dependent cysteine protease calpain in comparison with cell death 
patterns across three different mutant mouse lines, and wildtype (wt) 
mice. We determined the spatial activation of calpain during disease 
progression in the primary cone degeneration model cpfl1 and in the 
primary rod degeneration models rd1 and rd10, relative to wt controls 
and showed an increase in calpain activity in the rd1 and rd10 models 
in a spatio-temporal pattern. We used the TUNEL assay to stain for 
dying cells and found the spatiotemporal cell death pattern 
corresponding to that of calpain activity. Similarly, we observed up-
regulation of the calpain-2 isoform, whereas no up-regulation of 
calpain-1 was observed. In addition, we found an upregulation of 
apoptosis-inducing-factor (AIF) in the disease models compared to 
wt, while increases in caspase-3 activation were mainly found in 
cones late in the rd1 degeneration. Together these results indicate that 
calpain activity plays a role in the non-apoptotic photoreceptor cell 
death seen during retinal degeneration. 
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To further link the effects of Ca2+ dynamics to photoreceptor 
degeneration, we used a transgenic mouse line that expresses the 
HR2.1:TN-XL (TN-XL) Ca2+ biosensor in cones. We used two-
photon microscopy to study calcium levels and light-evoked 
responses in cone axon terminals in acute retinal slices (Kulkarni et 
al., 2015) before and after the application of the Ca2+ channel blockers 
L-cis (blocker of outer segment CNG channels) and D-cis (blocker of 
synaptic voltage gated calcium channels) diltiazem. Our data suggest 
that both diltiazem enantiomers lower baseline Ca2+ levels in cone 
terminals, while light-induced responses were altered only by the L-
cis enantiomer. To link Ca2+ dysregulation to calpain activation, we 
developed two-photon live imaging of calpain activity. With this 
approach, we disentangled part of the interaction between Ca2+-
mediated processes, calpain regulation, and photoreceptor cell death. 
Our data suggests a causal link between Ca2+ dysregulation and cell 
death, high-lighting a therapeutic target for future compound 
development.  
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Introduction 
Retinal organisation in mammals 
The retina is a highly specialised sensory tissue located in the back of 
the eye in mammals (Fig. 1) and is an outgrowth of the brain. Since 
sight is considered the primary sense in humans, one can say that the 
retina is the primary sensory tissue of the human body. The retina is 
composed of three cellular layers and two plexiform layers. Rod 
photoreceptors (rods) and cone photoreceptors (cones) in the outer 
nuclear layer (ONL) are responsible for the initiation of the 
phototransduction cascade within the retina. Photoreceptors (PRs) 
synapse onto bipolar cells in the inner nuclear layer (INL) which then 
relay the signal to the output neurons of the retina, the ganglion cells 
in the ganglion cell layer (GCL). This excitatory signal is modulated 
by two inhibitory interneuron classes: the horizontal cells in the outer 
plexiform layer (OPL) and by the amacrine cells in the inner 
plexiform layer (IPL) (Grossniklaus, Geisert, & Nickerson, 2015).  
22 
 
 
 
Fig.1 Scheme of a sagittal cross section of the mammalian retina.  
The retina is composed of two types of photoreceptors: rods and 
cones, which transmit signals to ganglion cells via bipolar cells. This 
signal is modulated by two inhibitory interneurons: the horizontal 
cells and amacrine cells. Müller cells are glial cells that support retinal 
physiological functions. Retinal neurons are organized into three 
different cellular layers: outer nuclear layer (ONL), inner nuclear 
layer (INL), and ganglion cell layer (GCL). These layers form two 
synaptic layers, one between the ONL and INL (outer plexiform 
layer; OPL), and one between the INL and GCL (inner plexiform 
layer; IPL). Modified from (Euler & Schubert, 2015).  
OPL 
ONL 
Rod 
Cone 
GCL 
Ganglion cell 
Müller glial 
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INL 
IPL 
Horizontal cell 
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Photoreceptor structure and function 
Photoreceptor structure 
Rods and cones are light sensing cells located in the outer nuclear 
layer of the retina, at the back of the eye. Both rods and cones are 
composed of four main cellular components: an outer segment, inner 
segment, cell body and the cell axon terminal (Fig. 2).  
The outer segments (OSs) are composed of dense stacks of membrane 
disks equally spaced apart that contain the visual pigment necessary 
for cellular function (rhodopsin in the case of rods, and opsins with 
different spectral tuning in the case of cones). The structural support 
provided by the abundance of the visual pigment is essential as 
rhodopsin knockout mice fail to properly form OSs. The large 
quantity of visual pigment in the OS of PRs greatly increases the 
chances of photon capture by the cells. 
The inner segment (IS) is a support structure for the OS in a number 
of ways. The IS not only physically supports the OS but also contains 
the Golgi apparatus and endoplasmic reticulum which are necessary 
to replace the huge protein turnover seen in the OS. The IS also 
contains many of the cells’ mitochondria, providing the energy 
needed for phototransduction. All proteins needed for the normal 
function of the OS must travel from the IS to the OS through the 
narrow connecting cilium. The cell soma contains the cell’s nucleus, 
responsible for DNA transcription before the RNA is transported to 
the endoplasmic reticulum in the IS. The synaptic terminal transmits 
24 
 
the light signal to the second order neurons of the retina, the 
horizontal and bipolar cells. In darkness, the cells maintain a steady 
stream of glutamate release controlled by calcium (Ca2+), to the 
horizontal and bipolar cells while this transmission is terminated in 
light. 
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Fig 2. Anatomical structure of mammalian photoreceptors 
Photoreceptors are composed of several distinct anatomical and 
functional compartments: the outer segment (OS) contains the visual 
pigment and cyclic nucleotide gated channels (CNGCs) and is 
responsible for phototransduction. The inner segment (IS) contains 
ribosomes and mitochondria to supply energy and proteins for the 
maintenance of the OS, the soma is responsible for gene expression 
and contains L-type Ca2+ channels. The axon terminals are 
responsible for glutamate release, controlled by L-type Ca2+ channels. 
Modified from (Euler & Schubert, 2015). 
 
At the plasma membrane, Ca²⁺ channels allow the entry of Ca²⁺ into 
the cell. Two types of Ca²⁺ channels are present at the plasma 
membranes of PRs. On the outer segments (OS) of PRs, cyclic 
nucleotide gated (CNG) channels are present (Butler et al., 2017) 
while voltage gated Ca²⁺ channels (VGCCs) are present on the cell 
body and cone pedicles (Morgans et al., 2005). Two different 
isoforms of VGCCs are expressed in PRs. Cone PRs contain α₁D 
VGCCs (Cav 1.3) on their cell bodies and terminals while rod PRs 
contain α₁F VGCCs (Cav 1.4) on their cell bodies and  terminals 
(McRory et al., 2004, Morgans et al., 2005). Cone CNG channels are 
composed of two structurally related subunits, CNGA3 and CNGB3 
(Kaupp & Seifert, 2002), while rod PRs are composed of three 
CNGA1 subunits and one CNGB1 subunit (Shuart, Haitin, Camp, 
Black, & Zagotta, 2011). While CNG channels are permeable to both 
sodium (Na+) and Ca²⁺ (~80% Na+, 15% Ca2+ and 5%Mg2+) (Yau, 
1994), CNG channels on the OS have increased Ca²⁺ permeability 
necessary for proper function with cone CNG channels showing 
higher Ca²⁺ affinity than those of rods (Hackos & Korenbrot, 1999).  
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Photoreceptor function 
Within the rod OS, rhodopsin acts as a receptor to the photons. Upon 
photon absorption, the rhodopsin molecule becomes enzymatically 
active resulting in the catalysis and activation of the G protein 
transducin. Transducin then activates phosphodiesterase-6 (PDE6), 
hydrolysing the diffusible secondary messenger cGMP. The resulting 
decrease in cytoplasmic free cGMP concentration leads to the closure 
of the cGMP-gated channels on the plasma membrane. Rods respond 
to light with graded hyperpolarization whose amplitude increases 
incrementally as a function of flash intensity until saturation. 
Reproducibility of a single photon response in both amplitude and 
kinetics is a hallmark of rod phototransduction (reviewed in Fu & 
Yau, 2007). In cone PRs the phototransduction is essentially identical 
to that of rods; although differences do exist. Light activated 
spectrally tuned opsins, rather than rhodopsin, are sensitive to light 
within cones with transducin, and PDE is still responsible for 
continuing the cascade (Kefalov, 2010). While rods are sensitive to 
one photon of light (Hecht, Shlaer, & Pirenne, 1942) cones are 40-
100 times less sensitive, requiring the simultaneous activation of tens 
to hundreds of visual pigment molecules to generate a detectable 
response (Kefalov, 2010).  
The biosensor TN-XL 
In 2005, the group of Oliver Griesback at the Max Planck Institute at 
Martinsried generated a FRET-based Ca2+ biosensor by utilising 
troponin C (TnC) as a Ca2+ binding moiety (Mank et al., 2006). They 
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generated a biosensor, dubbed TN-XL, by flanking the TnC moiety 
with a citrine and enhanced cyan fluorescent protein (ECFP) (Fig. 3). 
As this is a Förster resonance energy transfer (FRET)-based system, 
ratiometric analysis of the difference in levels of ECFP and citrine 
detected is utilised to determine the relative Ca2+ levels. When the 
cellular [Ca2+] increases, TnC undergoes a conformational change 
bringing the ECFP and citrine closer together, allowing ECFP to 
donate energy required to excite citrine. However, when cellular 
[Ca2+] is low, no conformational reconfiguration of the TnC peptide 
takes place and so excitation of the ECFP moiety results in 
measurement of the ECFP emission only. It was shown (Mank et al., 
2006) that TnC is an ideal candidate for Ca2+ signalling as the binding 
of Ca2+ is fast and stable with significant changes in fluorescence 
change. Mank et al. also reported that the off rate of this biosensor is 
faster than the fastest single fluorophore to date reported, and is 
significantly faster than double chromophore biosensors. TN-XL has 
stable and reproducible fluorescence properties, is pH insensitive in 
the physiological range due to the combination ECFP/citrine, folds 
well at room temperature and at 37°C, and offers the benefits of 
ratiometric imaging. 
The TN-XL biosensor was inserted into the cones in the mouse retina 
by Wei et al., (2012) through the use of a plasmid containing the 
human red opsin promoter (HR2.1) ensuring efficient transduction of 
cones. This stable incorporation of the TN-XL into the cones of the 
mouse retina allows for the measurement of Ca2+ dynamics within the 
cell upon the presentation of a light stimulus, as described in Kulkarni 
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et al., (2015). The incorporation of TN-XL into the cones allows 
indirect probing of the phototransduction cascade but does not affect 
the cellular morphology or electroretinogram (ERG) response. The 
fact that the TN-XL does not interfere with the light response of the 
cone may be due to the lack of the TN-XL in the OS. This lack of TN-
XL in the OS of the cell may be due to a lack of transporter proteins 
for the TN-XL within the cell, preventing its transport through the 
connecting cilium between the OS and IS (Kennedy & Malicki, 
2009). This lack of TN-XL in the OS restricts examination of the Ca2+ 
dynamics to the IS, cell body and cone terminals. Measurements of 
the Ca2+ dynamics in these structures are indirect measures, but the 
shared membrane potential of the cell allows us to partially infer the 
dynamics within the OS and the cell in general.   
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Fig 3. Schematic illustration of the TN-XL Ca2+ biosensor.  
Illustration of the TN-XL biosensor developed by Mank et al., (2006) 
with the construct generated by Wei et al., (2012). The TN-XL 
biosensor is comprised of a Ca2+ sensitive Troponin C peptide (TnC) 
flanked by an enhanced cyan fluorescent protein (ECFP) and a citrine 
protein under the control of the human red opsin 2.1 promoter 
(HR.2.1). The construct is expressed only in cones. When Ca2+ levels 
in the cones are low, the stimulation of the ECFP results in the ECFP 
HR2.1 ECFP Troponin C Citrine 
HR2.1: TN-XL 
promoter TN-XL 
432 476 nm 
Citrine 
ECFP 
Tn C 
Ca²⁺ Ca²⁺ Ca²⁺ 
Ca²⁺ 
Ca²⁺ 
Ca²⁺ 
432 nm 476 nm 528 nm 
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fluorescing. However, when Ca2+ levels are high, the TnC undergoes 
a conformational change in which, after the ECFP is excited, it 
donates energy to the citrine protein, exciting it and causing it to 
fluoresce.  
 
Retinal Dystrophies 
To date, more than 250 genes have been implicated in human retinal 
dystrophies (Berger, Kloeckener-Gruissem, & Neidhardt, 2010) (Fig. 
4). Due to their involvement in both the phototransduction cascade 
and Ca²⁺ homeostasis within the cell, we will focus here on diseases 
caused by mutations in Pde6 genes. Mutations causing PDE6 enzyme 
dysfunction have been implicated in night blindness and retinitis 
pigmentosa (Pde6a, Pde6b, Pde6g), cone-rod dystrophies(Pde6c, 
Pde6h) and colour vision defects (Pde6c) (Berger et al., 2010). 
Retinitis pigmentosa (RP) is a family of inherited diseases which 
present with clinical and genetic heterogeneity causing retinal 
dysfunction that leads to PR cell death (Daiger, Sullivan, & Bowne, 
2013; Farrar, Kenna, & Humphries, 2002; Sancho-Pelluz et al., 
2008). RP presents clinically as autosomal dominant, autosomal 
recessive or X-linked (Hamel, 2006; Humphries, Farrar, Kenna, & 
McWilliam, 1990; Kaplan, Bonneau, Frézal, Munnich, & Dufier, 
1990) with mutations in the Pde6 gene encoding the beta subunit of 
the protein linked to autosomal recessive RP (DANCIGER et al., 
1995; McLaughlin, Ehrhart, Berson, & Dryja, 1995; McLaughlin, 
Sandberg, Berson, & Dryja, 1993). RP affects more than one million 
individuals worldwide (Ammann, Klein, & Franceschetti, 1965; 
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Boughman, Conneally, & Nance, 1980; Jay, 1982) and autosomal 
recessive RP represents approximately 50-60% of those cases 
(Bunker, Berson, Bromley, Hayes, & Roderick, 1984; Grøndahl, 
1987; Novak-Lauš, Kukulj, Zoric-Geber, & Bastaic, 2002). 
Interestingly, the most severe cases of RP are autosomal recessive 
forms that occur within the first decade of life, while autosomal 
dominant are comparatively mild forms of RP and develop later in 
life (as late as age 50) (Hamel, 2006). As PDE6 is an essential part of 
the phototransduction cascade due to it hydrolysing cGMP, closing 
Ca²⁺ channels in the cell (Debora B Farber, 1995), mutations in the 
PDE6B result in an accumulation of the cGMP in the PR (Bowes et 
al., 1990; D B Farber & Lolley, 1976; Debora B Farber & Lolley, 
1974). This increase in levels of cGMP has also been shown to lead 
to PR cell death (Debora B Farber & Lolley, 1974; Lolley, Farber, 
Rayborn, & Hollyfield, 1977; Sancho-Pelluz et al., 2008) 
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Fig. 4. Schematic illustration of some of the genes involved in 
various retinal dystrophies. Clinical diagnoses are indicated by 
coloured circles but only those involving mutations in PDE6 have 
been highlighted. Gene symbols in the overlapping areas show that 
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mutations in the same gene can lead to different phenotypes. 
Modified from Berger et al., 2010. 
While the cellular mechanism leading to the cell death of the PRs has 
not been fully elucidated, the presentation of the disease in patients is 
better known. Initially patients complain of night blindness though 
this usually goes unnoticed until teenage years (Hamel, 2006). The 
disease then progresses to more complete loss of night time vision 
and a loss of peripheral vision during day: it is this stage that the 
disease is usually noticed by patients and diagnosed by clinicians 
(Hamel, 2006). The mid stages of the disease continue until the 
patients lose their ability to perform daily tasks and are considered 
legally blind. This continues to progress until finally the central field 
is lost, rendering them totally blind (Hamel, 2006).  
 
Disease models 
Retinal dystrophies are modelled in several animal models. In mice, 
mutations in the Pde6b located on chromosome five and causes the 
rod degeneration, such as in the rd1 mouse model (Sidman & Green, 
1965). The rd1 mutation is shown to model the autosomal recessive 
form of RP, making it as aggressive in the mouse as it is in humans 
(McLaughlin et al., 1995). Another model for RP which carries a 
Pde6b mutation is the rd10 mouse model. While a nonsense mutation 
in exon 7 of the Pde6b gene is the cause of the rd1 degeneration 
(Dräger & Hubel, 1978), a missense mutation in exon 13 of the Pde6b 
gene is the cause of the rd10 mouse’s visual defect (Chang et al., 
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2000). Due to the less aggressive nature of the rd10 mouse, cells in 
the retina have matured further before the degeneration occurs, unlike 
in the rd1 (Chang et al., 2007; Gargini, Terzibasi, Mazzoni, & 
Strettoi, 2007). The less aggressive nature of the phenotype is thought 
to be due to residual PDE6B in the rd10 preventing a toxic build-up 
of cGMP delaying the onset of the PR death (McLaughlin et al., 
1995).  
 
 
Fig.5 Scheme of a sagittal cross section through diseased 
mammalian retina.  
In RP, mutations in Pde6a or Pde6b leads to the death of rods 
followed by a secondary death of cones. This results in the thinning 
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of the ONL as seen here, before the ONL disappears entirely. Initially 
little change is seen in the INL or GCL initially, but after a more 
prolonged period of time these layers also undergo remodelling: outer 
nuclear layer (ONL), inner nuclear layer (INL), ganglion cell layer 
(GCL), outer plexiform layer (OPL), inner plexiform layer (IPL). 
Modified from (Euler & Schubert, 2015).  
 
For modelling achromatopsia in humans, the cone photoreceptor 
function loss 1 (cpfl1) mouse is used. Cone ERG recordings from the 
cpfl1 mouse show no light induced responses and while the retinas 
show normal structural development cone cell numbers diminish with 
age (Chang et al., 2001). Autosomal recessive mutations in the Pde6c 
gene on chromosome 19 in mice is responsible for the phenotype, 
mimicking the mutation for congenital achromatopsia in human 
(Chang et al., 2001).  
 
Calcium within the cells 
Ca²⁺ is the most abundant cation in vertebrates (20-30g/kg body 
weight, in humans) (Bringhurst, 1995) and is a common secondary 
messenger in the cell with proposed regulatory functions in cellular 
functions such as cell growth, differentiation, motility, and death 
(Berridge, 2012; Clapham, 2007). Upon binding to effector proteins 
such as calmodulin and synaptotagmins, Ca²⁺ regulates cellular 
processes such as gene transcription, secretion, and muscle 
contraction (Berridge, 2012; Clapham, 2007). Ca2+ concentrations 
([Ca²⁺]) in the cell are tightly regulated with resting cytosolic [Ca²⁺] 
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having a range of 50-300nM (Jacquemond, 1997; Maravall, Mainen, 
Sabatini, & Svoboda, 2000). Intracellular [Ca²⁺] is dwarfed by the 
concentrations in the extracellular environment (~ 2mM) (Berridge, 
Lipp, & Bootman, 2000) and by the concentration seen in intracellular 
organelles.  
Most intracellular organelles are known to act to some degree as Ca²⁺ 
stores. The endoplasmic reticulum (ER), Golgi apparatus, nucleus 
and mitochondria are all involved in the storage of Ca²⁺ within the 
cell (Bagur & Hajnóczky, 2017; Patel & Cai, 2015; Raffaello, 
Mammucari, Gherardi, & Rizzuto, 2016; Rizzuto, De Stefani, 
Raffaello, & Mammucari, 2012; Xu, Martinoia, & Szabo, 2015). The 
ER is the largest Ca²⁺ stores within the cell (Phillips & Voeltz, 2016) 
with Ca²⁺ concentrations in the ER estimated to be approximately 
5,000 times higher than that of cytosolic [Ca²⁺] (Berridge et al., 2000; 
Prakriya & Lewis, 2015). Sarcoendoplasmic reticulum Ca2+ transport 
ATPase (SERCA) pumps maintain inward flows of Ca²⁺ into the ER, 
while release of Ca²⁺ from the ER is enacted through inositol 1,4,5-
trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs) that 
release Ca²⁺ into the cytosol upon stimulation (Prakriya & Lewis, 
2015). Ca²⁺ within the ER can be rapidly mobilised into the cell 
although a single extracellular cue will only partially deplete this store 
(Berridge et al., 2000; Prakriya & Lewis, 2015). The ER is continuous 
with the nuclear envelope, with this membrane containing IP3R and 
RyR Ca²⁺ release channels in addition to SERCA pumps (Bootman, 
Fearnley, Smyrnias, MacDonald, & Roderick, 2009). IP3Rs, RyRs, 
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and SERCA are also expressed on the Golgi apparatus membranes 
(Pizzo, Lissandron, Capitanio, & Pozzan, 2011). The golgi apparatus 
hold unevenly distributed Ca²⁺ stores with trans-Golgi cisternae Ca²⁺ 
stores (~130µM) having lower concentrations than those of cis-Golgi 
cisterna (~250µM). Mitochondria are known to take Ca²⁺ into their 
matrix under high cytosolic [Ca²⁺] acting as a Ca²⁺ sink for the cell. 
Ca²⁺ within smaller cellular organelles such as lysosomes has been 
reported (Christensen, Myers, & Swanson, 2002; Lloyd-Evans et al., 
2008). It can be speculated that semi-continuous cellular organelles 
with a regular flow of Ca²⁺ may not occur in PRs. In PRs, 
mitochondria and ER are located in the inner segment, while the 
nucleus is spatially distant, located in the cell body. This distance 
would make it impossible for SERCA pumps to transport Ca²⁺ 
between the two organelles as their membranes are no longer 
continuous. Due to the more sequestered nature of the nucleus in PRs 
from the other Ca²⁺ stores within the cell, it is tempting to speculate 
that the dysregulation of Ca²⁺ would have to be severe to affect the 
nucleus and trigger cell death.  
Various Ca²⁺ stores within the cells have different roles and as such, 
their relationship with extracellular and cytosolic Ca²⁺ are very 
diversified. These differences between various Ca²⁺ storage 
compartments are not solely based on their rate of exchange but 
pertain also to their function. In the mitochondria Ca²⁺ has been 
shown to have a regulatory role in metabolism (Denton & 
McCormack, 1990; McCormack & Denton, 1994; McCormack, 
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Halestrap, & Denton, 1990). ER Ca²⁺ stores act as a rapidly accessible 
and mobilisable store, while the trans-Golgi network store has critical 
function in regulated luminal content packaging leading to the 
processing of secretory granules (reviewed in Pozzan, Rizzuto, 
Volpe, & Meldolesi, 1994). While Ca²⁺ is a widely used secondary 
messenger within the cell due to the large number of immobile Ca²⁺ 
binding sites within the cell, its diffusion is very slow (Allbritton, 
Meyer, & Stryer, 1992). The various Ca²⁺ stores within the cell, 
widely distributed throughout the cell, aid in overcoming this 
slowness of Ca²⁺ mobility. The activity of more rapidly diffusing 
secondary messengers such as inositol 1,4,5-trisphosphate (IP3) or 
self-perpetuating cellular mechanisms such as Ca²⁺ induced Ca²⁺ 
release (CICR), help ensure a more regulated maintenance of Ca²⁺ 
within the cell (reviewed in Pozzan et al., 1994).  
Ca2+ dysregulation 
Dysregulation of [Ca2+] has long been linked to cell death, but its 
exact role or underlying mechanism is still much debated (reviewed 
in Liu, Van Vleet, & Schnellmann, 2004; Rizzuto et al., 2003). The 
“high Ca²⁺” hypothesis was put forward by (Fox, Poblenz, & He, 
1999) who theorised that high intra-cellular [Ca²⁺] leads to cell death. 
Some believe that Ca2+ dysregulation triggers apoptosis (Orrenius, 
Zhihotovsky, & Nicotera, 2003), while others refute this arguing that 
caspases, the proteases responsible for the activation and progression 
of apoptosis, are not upregulated in models of RP nor achromatopsia 
(Arango-Gonzalez et al., 2014; Doonan, Donovan, & Cotter, 2005). 
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Confusion may occur from apoptosis becoming a catch all term for 
any form of cell death seen, even when caspases are shown to not be 
activated (Donovan & Cotter, 2002; Doonan, Donovan, & Cotter, 
2003). Hence, the exact mechanism driving PR cell death in these 
diseases is still unknown. Ca²⁺ dysregulation has been linked to 
mitochondrial damage leading to the release of pro-apoptotic proteins 
or pro-oncotic proteins from the organelle (Liu & Schnellmann, 2003; 
Orrenius et al., 2003; Pinton, Giorgi, Siviero, Zecchini, & Rizzuto, 
2008). It has also been shown that an unregulated Ca²⁺ uptake leads 
to cell death through the unfolded protein response (UPR) in the 
endoplasmic reticulum. Cell death involving low [Ca²⁺] is less well 
studied although as Ca²⁺ is necessary for so many cellular functions: 
the lack of Ca²⁺ would undoubtedly have disastrous effects.  
 
The Calpain family  
Calpains are a family of cytosolic cysteine proteases whose 
enzymatic activities are dependent on Ca²⁺. To date, 15 calpain 
isoforms have been discovered in mammals. The calpain family can 
be subdivided into typical (calpain 1, 2, 3, 8, 9, 11 and 12) and 
atypical calpains (calpain 5, 6, 7, 8b, 10a and 15) (Huang & Wang, 
2001; Sorimachi, Ishiura, & Suzuki, 1997). Each of these calpain 
isoforms are an 80kDa protein but only some of them (calpain 1, 2 
and 9) interact with the regulatory 30kDa calpain-4 (Huang & Wang, 
2001; Sorimachi et al., 1997). This interaction has caused some 
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nomenclature issues. When interacting with the small regulatory 
calpain-4, calpain-1 and calpain-2 are referred to as µ-calpain and m-
calpain respectively. Calpains are constitutive enzymes but cannot be 
considered household proteins as the transcription of their genes is 
regulated (Cottin et al., 1994) by a promoter while most household 
proteins are constitutively transcribed. Both calpain-1 and -2 are 
expressed in every cell in the mammalian body (Huang & Wang, 
2001; Sorimachi et al., 1997) while others calpain-3 and calpain 8, 
are expressed only in specific tissues (Suzuki, Hata, Kawabata, & 
Sorimachi, 2004). Calpains have been implicated in several cellular 
functions including signal transduction, cell proliferation, cell cycle 
progression, differentiation, apoptosis, membrane fusion and platelet 
activation (Carafori, 1998; Huang & Wang, 2001; Saido, Sorimachi, 
& Suzuki, 1994; Sorimachi et al., 1997). Here, we will focus on 
calpain-1 and calpain-2, two extensively studied isoforms of the 
calpain family, which are expressed in the retina. 
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Fig. 6 Evolutionarily conserved calpain isoforms  
Calpain proteases are ubiquitously expressed and have been identified 
in almost all cell types. The evolutionarily conserved protease domain 
has been maintained in almost all calpain isoforms in all forms of life 
except for the atypical mammalian calpain 16. This would also point 
to the ubiquitous use of Ca²⁺ in all cell types, as calpain are dependent 
on Ca²⁺ for activation. Figure taken from Calpain for Modulatory 
Proteolysis Database, 
http://www.calpain.org/overview.rb?cls=calpain taken 13/11/2018. 
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Calpain structure 
Both calpain-1 and calpain-2 are composed of an 80kDa active 
subunit and the regulatory 30kDa subunit. The 80kDa subunit of 
calpain-1 is slightly larger than that of calpain-2 (81,889Da compared 
to 79,900 Da) (Aoki et al., 1986; Imajoh et al., 1988). Generation of 
two-knockout mice proved embryonically lethal, demonstrating that 
these proteases are essential for life 
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Fig.7 Crystallised structure of m-calpain without Ca²⁺ 
Structure of m-calpain without Ca²⁺. As can be seen domains I-IV of 
calpain-2 contain several Ca²⁺ binding sites as does the regulatory 
calpain-4 which forms domains V and VI. The catalytic triad of C105, 
H262 and N286 can be seen in domain IIa. Image from Suzuki et al., 
(2004). 
 
however, mice with calpain-1 knockout survived showing that only 
calpain-2 is essential for normal embryonic development (Arthur, 
Elce, Hegadorn, Williams, & Greer, 2000; Azam et al., 2001). 
Calpain-1 and calpain-2 are both composed of four protein domains 
(Suzuki, 1990). The regulatory subunit calpain-4 contains two 
domains bringing the total number of subunits on m- and µ-calpain to 
six (Suzuki, 1990). 
 
Calpain activation 
While calpains are expressed in every cell, they are not constitutively 
active but rather are activated in a number of steps by Ca²⁺. Calpain-
2 has been discovered to have 11 Ca²⁺ binding sits across the six 
domains (two on domain II, two on domain III, four on domain IV, 
and three on domain VI) and due to the sequence homology the same 
can be assumed for calpain-1. Domain II forms the active site of 
calpain-1 and calpain-2 with the catalytic triad of amino acids (aa). 
The catalytic triad is composed of, a cysteine (aa 115 or 105 on 
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calpain-1 and calpain-2 respectively), a histidine (aa 272 or 262) and 
an asparagine (aa 296 or 286) (Moldoveanu et al., 2002).  
 
Molecular mechanism of calpain activation 
Calpain activation is controlled by Ca²⁺ and is aided by the autolysis 
of domain I. Autolysis occurs 40 Angström (Å) from the catalytic 
active site and so is not an intermolecular event (Suzuki, 1990). 
Autolysis of calpain-1 involves the removal of 14aa from the 80kDa 
subunit, forming a 78kDa intermediate before a further 12aa are 
removed to form the 76kDa autolytic fragment (Zimmerman & 
Schlaepfer, 1991). For calpain-2, nine n-terminal aa are removed 
before an additional 10 are cleaved off, producing a 78kDa fragment 
(Brown & Crawford, 1993). Binding of Ca²⁺ induces conformational 
changes by breaking salt bridges between a set of glutamine and 
asparagine residues and a set of lysine aa allowing domain IIb to 
move toward domain IIa (Strobl et al., 2000). This movement allows 
the formation of the catalytic triad by reducing the distance of the 
cysteine residue 10.5 Å to ~3.7 Å from the histidine and asparagine 
making the calpain catalytically active (Reverter, Sorimachi, & Bode, 
2001).  
[Ca²+] required for calpain activation 
Investigation of calpain-1 and -2 in bovine skeletal muscle revealed 
the levels of Ca²⁺ required for half maximal activity of both calpains. 
Autolysis of calpain-1 lowers the [Ca²⁺] required for proteolytic 
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activity from a range of 3-50µM to 0.5-2µM (Cong, Goll, Peterson, 
& Kapprell, 1989; D E Goll, 1995). Autolysis of calpain-2 however 
lowers [Ca²⁺] required for proteolytic activity from 400-800µM to 50-
150µM (Cong et al., 1989; D E Goll, 1995).  The concentration of 
Ca²⁺ for autolysis of calpain was shown to be lowered by the 
interaction with phospholipids (Coolican & Hathaway, 1984).  
Lowering the threshold required for calpain activation 
Phosphatidylinositol was shown to be the most effective at lowering 
the [Ca²⁺] for calpain autolysis (from 50-150µM to 0.8-50µM from 
for calpain-1, 550-800µM to 90-400µM for calpain-2) (Cong et al., 
1989). Other phospholipids such as phosphatidylinositol 4,5-
bisphosphate (PIP2) reduced the concentrations needed for autolysis 
by approximately six-fold (Cong et al., 1989; Saido, Mizuno, & 
Suzuki, 1991; Saido, Shibata, Takenawa, Murofushi, & Suzuki, 
1992). Phospholipids are thought to bind to domain III of calpain 
which suggests phospholipids have an effect on the structure of other 
calpain domains as domain III does not seem to have any Ca²⁺ binding 
sites (Tompa, Emori, Sorimachi, Suzuki, & Friedrich, 2001). 
However, it was shown in in vitro assays that high molar ratios of 
375-4,100 phospholipids to each calpain was needed to have an effect 
on the [Ca²⁺] required for autolysis (Cong et al., 1989; D E Goll, 
1995). Others report that calpains do not bind to the phospholipids 
but rather proteins on the plasma membranes (Inomata, Hayashi, 
Nakamura, Saito, & Kawashima, 1989; Inomata, Saito, Kon, & 
Kawashima, 1990; Kuboki, Ishii, & Kazama, 1990). Regardless of 
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whether calpain interacts with the phospholipids or proteins on the 
plasma membrane, one may speculate that this interaction locates the 
calpain closer to Ca²⁺ channels, helping to further activate the 
protease. 
Functional roles for calpain 
Calpain isoforms have been implicated in cellular functions such as 
signal transduction, cell cycle, proliferation, differentiation, 
migration, apoptosis, membrane function, formation of muscle fibres, 
dendritic spine formation and pruning, and many others. We will 
discuss some of these here (Darrel E Goll, Thompson, Li, Wei, & 
Cong, 2003; Kanamori et al., 2013; Smalheiser & Lugli, 2009; 
Sorimachi et al., 1997).  
Calpain in fertilisation 
Calpain proteases are vital for survival. Calpain-2 knockout mice are 
shown to be embryonically lethal (Dutt et al., 2006). This is probably 
due to the fact that an increase in intracellular [Ca²⁺] is the earliest 
event in the activation of fertilised egg induced by penetration of the 
sperm cell (D, 1992). Fertilisation of the egg is accompanied by the 
activation of calpain (Haim, Ben-Aharon, & Shalgi, 2006), as 
estimated by the cleavage of α-spectrin into calpain specific products 
(Haim et al., 2006). 
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Calpain in diabetes 
Polymorphisms within intron 3 the calpain 10 gene (Baier et al., 
2000) have been associated with increases in free fatty acids and 
insulin resistance (Orho-Melander et al., 2002). Mutations within the 
calpain 10 results in upregulation of protein kinase C (a calpain 
substrate) leading to hyperphosphorylation of the insulin receptors 
reducing the kinase activity of these insulin receptors, increasing 
insulin resistance (Griffin et al., 1999; Suzuki et al., 2004).       
 
Calpain in oncosis/necrosis 
Calpain has been implicated in a variety of the physiological changes 
seen during oncosis/necrosis. Cellular membrane permeability (a 
hallmark of oncosis) is thought to occur in three stages, with each 
stage increasing permeability from propidium iodide in stage one, to 
allowing the release of 130kDa Lactate dehydrogenase (LDH) in 
stage three (J Chen & Mandel, 1997; Jing Chen, Liu, Mandel, & 
Schnellmann, 2001). Increases in calpain proteolysis have been 
linked to the increased plasma membrane permeability. Hydrolysis of 
paxillin occurs at the same time as propidium iodide entry, while 
hydrolysis of cytoskeletal proteins talin and vinculin occurs 
concomitantly with LDH release (Liu & Schnellmann, 2003). 
Calpain promotes disruption and hyperpermeability in the blood brain 
barrier (BBB) through disruption of the tight junctions in vitro (Alluri 
et al., 2016). It was shown that calpain mediated dysfunction of the 
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BBB was induced by interleukin-1β (IL-1β) and this disruption of the 
BBB was abolished with calpain inhibition (Alluri et al., 2016). IL-
1β is a marker for inflammation in mammalian tissues and the 
involvement of calpain in an inflammatory response (also associated 
with oncosis) suggests links between calpain and oncosis.   
Calpain in apoptosis 
Apoptosis is a programmed form of regulated cell death carried out 
by the caspase family of proteins (discussed further below). The role 
of calpain in apoptosis is difficult to fully elucidate due to a 
combination of improper nomenclature and the use of calpain 
inhibitors which also inhibit other molecules more well established in 
the apoptosis pathway. Especially the interactions between caspases 
and calpains are complex to understand. It has been shown that 
calpains cleave caspase-7, -8 and -9 inactivating capase-7 and -8 
(Chua, Guo, & Li, 2000). However, calpain-2 has been suggested to 
cleave procaspase-12, activating it and cleaving the Bcl-xl loop 
region and changing it from an anti-apoptotic molecule into a pro-
apoptotic molecule (Nakagawa & Yuan, 2000).  
Activation of calpain in apoptotic HL-60 cells by treating them with 
the topoisomerase I inhibitor 9-amino-20(s)-camptothecin, was 
shown to occur after the activation of the caspase molecules and at 
the same time as the cleavage of Bax (Wood & Newcomb, 1999). 
This activation of calpain was theorised to be mediated through 
caspase degradation of calpastatin but this apoptosis was not stopped 
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by calpain inhibition, indicating that calpain activation was a 
consequence of apoptosis, but not a driver of it.  
The nature of the insult has been shown to have a role in the method 
of apoptosis. In human platelets, calpain-1 was shown to activate the 
apoptosis through caspase-9, caspase-3, apoptotic protease activating 
factor 1 (APAF-1) and, cytochrome-c and not by other caspases. Anti-
IgM induced apoptosis in immature B-cells was blocked by 
overexpressing calpastatin but, actinomycin D induced apoptosis in 
the same cell line was not stopped by calpastatin overexpression. 
Due to the different roles of calpain-1 and calpain-2 and their 
differential expression, the role of each calpain isoform in apoptosis 
may be difficult to fully elucidate by the use of different cell lines and 
cell types. Greater stringency in the cell lines used, and the conditions 
the cells are kept in, need to be asserted in order to properly determine 
the relationship between calpain and caspases in the execution of 
apoptosis. 
Cell death mechanisms 
Recently Galluzzi et al. published the findings of the nomenclature 
committee on cell death (Galluzzi et al., 2018) where the definition 
of several forms of cell death were updated. Some of these relevant 
to Ca2+ dysregulation in PRs, we will discuss here. Alongside these 
modes of cell death from Galluzzi et al. we will discuss two more 
which they did not examine.  
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Cell death is an essential part of life and is the irreversible 
degeneration of vital cellular functions (notably ATP production 
and preservation of redox homeostasis) culminating in the loss of 
cellular integrity (permanent plasma membrane permeabilization 
or cellular fragmentation) (Galluzzi et al., 2018). Cell death can be 
regulated (i.e. results from the activation of one or more signal 
transduction modules, and hence can be pharmacologically or 
genetically modulated) (Galluzzi et al., 2018) or unregulated. In the 
case of regulated cell death, some forms are programmed cell death 
which occur in strictly physiological scenarios, i.e., it does not 
relate to perturbations of homeostasis and hence does not occur in 
the context of failing adaptation to stress (Galluzzi et al., 2018). 
Cell death 
mechanism 
Markers Reported 
in PRs 
Linked to 
Ca2+ 
dysregulation 
Regulated/ 
Unregulated 
Anoikis Loss of 
Integrin-
dependen
t 
anchorag
e 
- Yes Regulated 
Mitochondria
l permeability 
transition -
driven 
necrosis 
CYPD - Yes Regulated 
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Parthanatos PARP1, 
AIF, MIF 
Yes Yes Regulated 
Necroptosis MLKL, 
RIPK3, 
RIPK1 
Yes Yes Regulated 
 
Table 1. List of diverse forms of cell death and their relationship 
to reported mechanisms of PR cell death and Ca2+ dysregulation. 
Apart from these definitions we will also discuss apoptosis, 
oncosis, and necrosis though these are harder to succinctly define.  
Intrinsic apoptosis is type of regulated cell death initiated by 
perturbations of the extracellular or intracellular 
microenvironment, demarcated by mitochondrial outer membrane 
perturbations (MOMP), and precipitated by executioner caspases, 
mainly caspase-3 (Galluzzi et al., 2018). 
Oncosis/Necrosis 
Oncosis is often used in place of necrosis in the literature, although 
Weerasinghe & Buja, (2012) described oncosis as a form of cell 
death opposite to apoptosis, marked by a drop in ATP and 
completed through a necrotic form of cell death, suggesting that all 
oncosis is necrotic but not all necrosis is oncotic. Oncosis is a more 
zonal form of tissue cell death than apoptosis which affects cells on a 
more singular basis (Majno & Joris, 1995). Oncosis often affects 
contiguous cell populations (Majno & Joris, 1995) resulting in 
cellular swelling, formation of cytoplasmic vacuoles, distended 
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endoplasmic reticulum, formation of cytoplasmic blebs, condensed, 
swollen or ruptured mitochondria, disaggregation and detachment of 
ribosomes, disrupted organelle membranes, swollen and ruptured 
lysosomes, and even disruption of the cell membrane (Kerr, Wyllie, 
& Currie, 1972; Majno & Joris, 1995; Trump, Berezesky, Chang, & 
Phelps, 1997). These structural changes in the cell are followed by 
plasma membrane breakdown, release of intracellular contents, and 
inflammation (Majno & Joris, 1995). Unlike apoptosis, oncosis is a 
passive process and so can take place regardless of the ATP 
concentration within the cell (Leist, Single, Castoldi, Kühnle, & 
Nicotera, 1997).  
Necrosis was defined by Fink & Cookson, (2005) as “postmortem 
observation of dead cells that have come into equilibrium with their 
environment”, while J.M. Cullen, (2010) defined necrosis as “cell 
death caused by loss of membrane integrity, 
intracellular organelle swelling and adenosine triphosphate (ATP) 
depletion leading to an influx of Ca2+.” Interestingly, J.M. Cullen, 
(2010) continued by suggesting that this influx of Ca2+ led to the 
disruption of the cellular cytoskeleton, leading to the destruction of 
cellular elements. Although never mentioned by Cullen, cytoskeleton 
proteins are targets of calpain and so this activity could be ascribed to 
calpain. Here we will discuss more deeply two types of cell death 
modes employed by the cell for a variety of insults and the role 
calpain is theorised to play in both.  
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Apoptosis 
Apoptosis is an essential, genetically regulated and finely tuned 
process of cell elimination essential for tissue maintenance, 
embryogenesis and development (Kerr et al., 1972). Apoptosis is an 
essential part of normal development and has functions in organisms 
as diverse as nematodes, insects and humans (Twomey & McCarthy, 
2005). Cell death by apoptosis is characterised by a series of events 
including cell collapse, formation of membrane blebs, chromatin 
condensation, and DNA degradation (Kerr et al., 1972). Due to the 
shrinkage of the cells, the cytoplasm appears denser and the 
organelles more tightly packed. The caspase family has been 
discovered to be central regulators of apoptosis with at least 14 
members of the caspase family present in the cell as proenzymes 
before activation (Donovan & Cotter, 2002). Our understanding of 
the mechanisms involved in apoptosis in mammalian cells comes 
from the investigation of programmed cell death in the nematode 
Caenorhabditis elegans (Ellis & Horvitz, 1986). Apoptosis has been 
recognised as a distinctive and important form of “programmed cell 
death” which involves genetically timed removal of cells though 
several other forms of programmed cell death have been discovered 
(Debnath, Baehrecke, & Kroemer, 2005; Formigli et al., 2000; 
Howden et al., 2005; Sperandio, de Belle, & Bredesen, 2000). 
Extensive blebbing of the plasma membrane is followed by 
karyorrhexis and separation of cell fragments into apoptotic bodies 
during the “budding” process (Howden et al., 2005). Apoptosis is a 
process without inflammation or tissue swelling for three reasons: 1) 
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apoptotic cells do not release their cellular contents into the 
surrounding tissue, 2) they are quickly phagocytosed by surrounding 
cells, and 3) the engulfing cells do not produce anti-inflammatory 
cytokines (Kurosaka, Takahashi, Watanabe, & Kobayashi, 2003; 
Savill & Fadok, 2000). 
 
Choosing the right for of cell death mechanism for the dying cell 
As several forms of programmed cell death other than apoptosis have 
been discovered (Debnath et al., 2005; Formigli et al., 2000; Howden 
et al., 2005; Sperandio et al., 2000), the involvement of caspase 
proteases is the best indication that apoptosis is occurring and not 
another form of cell death. Necrosis is less easy to define by protein 
involvement although apoptosis inducing factor (AIF) has been 
implicated in the necrotic process within cells (Shang et al., 2014). 
Several factors may determine whether a cell uses necrosis or 
apoptosis to die. The availability of energy is a large determinant. As 
necrosis is a passive process, which does not require ATP, it has long 
been suspected that the levels of ATP in the cell are a determining 
factor for whether the cell chooses apoptosis or necrosis to complete 
cell death under stress (Criddle et al., 2007; Leist et al., 1997; 
Tsujimoto, 1997). If levels decreases in ATP drop to less than 80-
85%, the cell will die by apoptosis or survive if mitochondrial 
function can be restored (Lieberthal, Menza, & Levine, 1998). If, 
however, ATP depletion is greater than 80-85%, necrosis will occur 
(Lieberthal et al., 1998). The type or degree of stimuli determines if 
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the cell die by apoptosis or necrosis. At low doses, stimuli such as, 
heat, radiation, hypoxia, and cytosolic anticancer drugs can induce 
apoptosis but these same stimuli result in necrosis at higher doses or 
prolonged exposure (Elmore, 2007). 
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Aims 
While mutations in PDE6 have been known to result in dysregulation 
of Ca2+ within the cells, the exact effects of this are still much debated. 
Here, we aim to further elucidate the effects of this Ca2+ 
dysregulation, including the mechanism of cell death it leads to. 
Knowing the mechanism utilised by the cell machinery to kill the cell 
could allow for new therapeutic developments and eventually 
effective clinical interventions to treat retinal degeneration.  
The aims of this study are: 
1. Investigate the levels of calpain activity across the retina as 
a marker for Ca2+ dysregulation and examine whether and to 
what extent calpain-1 and -2 may be implicated with this 
activity. 
2. Measure the levels of cell death in the retina using the 
TUNEL assay and further elucidate the cell death 
mechanisms using markers for different cell death pathways, 
t-AIF and cleaved caspase-3. 
3. Investigate the temporal and spatial progression of the six 
markers (calpain activity, calpain-1, calpain-2, TUNEL, AIF 
and caspase-3) across wild-type and degenerating retina.  
4. Measure light mediated Ca2+ responses in cones using two-
photon microscopy and Ca2+ channel blockers to assess how 
blocking Ca2+ channels affect light responses and cellular 
Ca2+ concentration.   
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5. Develop a methodology for the simultaneous imaging of 
calpain activity and calcium levels in individual 
photoreceptors. 
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Materials and Methods 
Animals for two-photon Ca2+ imaging: The transgenic mouse line 
HR2.1:TN-XL (C57BL/6J background) expresses the Ca2+ biosensor 
TN-XL (Mank et al., 2006) under the control of the human red opsin 
promoter (HR2.1) selectively in cone PRs (Wei et al., 2012). The TN-
XL biosensor was crossbred with the C57BL/6J mouse to allow us to 
study Ca2+ dynamics within the cone terminals. Animals from these 
lines were used irrespective of gender. For measuring Ca2+ responses 
in HR2.1:TN-XL mice were used regardless of age ranging from P34-
P181. For imaging calpain under the two-photon HR2.1:TN-XL x rd1 
mice aged between P11-P13 were used while wt mice were used 
regardless of age (P19-P249). In brief, for all imaging experiments, 
mice were dark adapted for two hours. They were deeply anesthetized 
with isoflurane (CP-Pharma, Germany) and then sacrificed by 
cervical dislocation. 
Animals. To study primary and secondary cone degeneration, rd1 
(C57BL/6J x C3H background) and cpfl1 (C57BL/6J) mutant mouse 
models were used. We used the more slowly degenerating rd10 mice 
(C57Bl6/J) to assess primary rod degeneration at a longer timescale 
than rd1 and because in rd10, developmental and degenerative cell 
death are temporally less overlapping. Animals from these lines were 
used irrespective of gender. Wild-type and mutant rd1 and cpfl1 mice 
were crossbred with the transgenic mouse line HR2.1:TN-XL 
(C57BL/6J background), which expresses the Ca2+ biosensor TN-XL 
(Mank et al., 2006) under the control of the human red opsin promoter 
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(HR2.1), selectively in cone PRs (Wei et al., 2012). The mouse lines 
thereby generated were the HR2.1:TN-XL x cpfl1and HR2.1:TN-XL x 
rd1 lines; for simplicity, we refer to these biosensor lines in the 
following as wt, cpfl1, and rd1. In the context of the present study, 
these mouse lines allow for a direct identification of cone PRs. 
Animals above P12 were sacrificed by CO2 asphyxiation followed by 
cervical dislocation. Mice below P12 were sacrificed by decapitation. 
All procedures were performed in accordance with the law on animal 
protection issued by the German Federal Government 
(Tierschutzgesetz) and approved by the institutional animal welfare 
board of the University of Tübingen.  
 
Calpain activity assay. Following earlier work (Kulkarni, Trifunović, 
Schubert, Euler, & Paquet-Durand, 2016), calpain activity was 
initially analysed in mice at  P14, 18, 24, 30, 60, 90 and 120 
(Supplemental Table 1). In rd1 and, for comparison, wt, we added 
P10 and 12, as degeneration peaks early in the rd1 mutant. Eyes were 
marked on the nasal side prior to enucleation, flash-frozen in liquid 
N2, embedded in Tissue-Tek OCT compound (Sakura Finetek 
Europe, Alphen aan Den Rijn, Netherlands), and stored at -20°C until 
cryo-sectioning into 16µm thick vertical sections. Sections were 
rehydrated in calpain reaction buffer (CRB) (5.96g HEPES, 4.85g 
KCl, 0.47g MgCl₂, 0.22gCaCl₂ in 100ml ddH₂O; pH 7.2) with 2mM 
dithiothreitol (DTT), and then incubated for 2h at 37°C in CRB 
containing 50µM of tBOC-Leu-Met-CMAC (Molecular Probes), a 
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calpain-specific substrate, whose fluorescence increases after 
cleavage by calpain (Francois Paquet‐Durand et al., 2006).  
 
Immunohistochemistry. For immunostainings, we analysed mice at 
P10, 12, 14, 18, 24, and 30 (Supplemental Table 1). Due to the lack 
of a discernible outer nuclear layer (ONL) in rd1 and rd10 post P30-
animals, and the lack of significant difference in calpain activity in 
cpfl1 and wt post P30-animals, we limited our examination to time 
points between P10 and P30. Eyes were fixed in 4% PFA in 0.1M 
phosphate buffer saline (PBS, pH 7.4; for 45mins) and cryo-protected 
in sucrose gradients in PBS at room temperature for 2hrs. Then, eyes 
were embedded in Tissue-Tek OCT cryomatrix (Sakura Finetek 
Europe, Alphen aan Den Rijn, Netherlands) and stored at -20°C until 
cryo-sectioning into 16µm thick vertical sections. Sections were 
rehydrated with PBS, permeabilized in 0.3% Tween in PBS 
containing blocking solution (10% goat serum, 1% BSA). As primary 
antibodies, we used rabbit anti-calpain-2 (ab39165; 1:300; Abcam, 
Cambridge, UK), rabbit anti-calpain-1 (ab39170; 1:100; Abcam, 
Cambridge, UK), rabbit anti-cleaved-caspase-3 (#9664; 1:300, Cell 
Signalling Technology, Frankfurt, Germany) and, rabbit anti-AIF 
(ab1998; 1:350; Abcam, Cambridge, UK). As secondary antibodies, 
we used Alexa Fluor 488 goat anti-rabbit (1:350; Molecular Probes, 
Eugene, USA). 
 
Cell death detection: For the detection of cell death, we analysed mice 
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at P10, 12, 14, 18, 24, and 30 (Supplemental Table 1). The terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) 
assay was performed using the TMR red kit from Roche Diagnostics 
(Mannheim, Germany). Sections were incubated in blocking solution 
(1% BSA, 10% normal goat serum, 1% fish gelatine for 1hr after 
5mins incubation with alcohol acetic acid mixture (62% EtOH, 11% 
Acetic Acid, 27% H₂O). Sections were then incubated with TMR red 
TUNEL kit as per manufacturer’s instructions.  
 
Microscopy and image processing. Z-stack images were captured on 
an Imager Z1 ApoTome microscope using a 20x air objective (0.8 
NA; cf.), and Zen (v.2.3 Pro) software (Carl Zeiss Microscopy 
GmbH, Oberkochen, Germany). Zen Lite v.2.3 software was used to 
reconstruct images and ImageJ 1.52e (http://imagej.nih.gov/ij) was 
used to count positive markers in each image. Figures were generated 
in IGOR Pro (Wavemetrics, Lake Oswego, USA) and arranged in 
Canvas 11 (ACD Systems International Inc., Seattle, USA).  
 
Analysis of marker data. Data was obtained from at least three 
different animals for each parameter examined. For each animal, 
vertical sections were quantified using collapsed Z-stacks of n=~16, 
0.75µm-spaced images acquired at 20x magnification (Supplemental 
Table S1). For each section, five regions across the retina were 
imaged and analysed (Supplementary Fig. 1). Calpain-active, as well 
as calpain-2-, calpain-1-, caspase-3-, AIF-, and TUNEL-labelled cells 
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were counted and expressed as number of positive cells in the ONL 
per 1,000µm² in all mouse lines, at all time points. Statistical 
comparisons were made using the Kruskal–Wallis one-way analysis 
of variance test using GraphPad Prism 7 (La Jolla, USA). Dunn’s 
posthoc test was performed after Kruskal-Wallis and measured 
variance between the groups at each time point but not between time 
points.   
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Figure 8. Illustration of the preparation protocol. Mouse eyes were 
marked nasally before being enucleated, dissected, fixed, and flash 
frozen in liquid nitrogen before sectioning. Eyes were sectioned from 
the nasal side towards the temporal side along the dorso-ventral axis 
(A). Consecutive sections were kept on consecutive slides (B). 
Sections were imaged along the dorso-ventral axis at five locations: 
Dorsal, Dorsomedial, Medial, Ventromedial and Ventral (C). Images 
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were then analysed (D) by measuring the whole retinal area imaged 
(yellow dashed line), the ONL area imaged (red dashed line) and, 
ONL length imaged (green dashed line) for each image. ONL width 
was calculated by dividing the area by the length for each image.  
 
 
Gaussian process modelling. Gaussian process models were used to 
estimate the mean and standard deviation of the activity of each cell 
death marker for each mouse line at the observed time points. These 
models were used as they can accommodate the non-linear change in 
the level of each marker and provide a generative model for 
estimating properties of interest (in our case, the likely peaks for each 
marker). Modelling was performed in Python 3.5 using the GPy 
(“GPI A gaussian Process Framew. phython,” 2012) library. All 
Gaussian Process (GP) (Williams & Rasmussen, 2006) models used 
radial basis function kernels and additive Gaussian likelihood noise, 
and were optimised using the L-BFGS-B maximum likelihood 
algorithm. Prior to model fitting, a square root transformation was 
applied to the data to accommodate the left-skew and zero-bound; the 
inverse transformation was applied for subsequent inference. A 
distribution over the maxima of each GP was inferred by drawing 
1,000 samples from the posterior of each fitted model. 
 
Generation of heat maps. During retinal sectioning, order and 
orientation of sections was maintained and the retinal location of each 
image determined using the section number and the distance from the 
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optic nerve head along the section, providing x- (nasal-temporal) and 
y-coordinates (dorsal-ventral), respectively. To visualise the spatio-
temporal progression of the markers, the mean activity at each 
location along the dorsal-ventral axis was used (averaging over the 
nasal-temporal dimension) and plotted for against each time point. 
Heat-maps were generated in Python 3 using the matplotlib library. 
 
Two-photon Ca2+ imaging. The preparation of retinal slices for Ca2+ 
imaging was performed as described previously (Kulkarni et al., 
2015; Wei et al., 2012). All preparations were performed under red 
light, eyes were enucleated and dissected in carboxygenated (95% O2, 
5% CO2) artificial cerebral spinal fluid (ACSF) solution, made with 
(in mM): 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4, 26 
NaHCO3, 0.5 L-glutamine, and 20 glucose (Sigma-Aldrich or Merck, 
Germany); maintained at pH 7.4 using carboxygen. Consecutive 
vertical slices (~200 μm thick) were cut using a tissue slicer (Werblin, 
1978) and then transferred to the two-photon microscope recording 
chamber where they were constantly perfused with warmed (~37°C) 
ACSF. The microscope (Euler et al., 2009), consisted of a customized 
MOM (movable objective microscope; designed by W. Denk, MPI of 
Neurobiology, Martinsried; purchased from Science Products/Sutter 
Instruments, Novato, USA), equipped with a mode-locked 
Ti:Sapphire laser (MaiTai-HP DeepSee; Newport Spectra-Physics, 
Darmstadt, Germany) tuned to 860 nm, two fluorescence detection 
channels (483 band-pass (BP) 32; 535 BP 50; AHF, Tübingen, 
Germany), and a 20x water-immersion objective (XLUMPlanFL, 
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0.95 NA; Olympus, Hamburg, Germany). The system was controlled 
by the image acquisition software ScanM (by M. Müller, MPI of 
Neurobiology, Martinsried, Germany, and T.Euler) running under 
IGOR Pro 6.3. A custom-built dichromatic light stimulator (Baden et 
al., 2013), equipped with two band-pass filtered LEDs (UV filter: 360 
BP 12; green: 578 BP 10) and mounted below the recording chamber, 
was used to present temporally-modulated, full-field light stimuli 
(approx. 2 mm in diameter) to the retinal slices. Ca2+ recordings were 
performed with a constant background illumination of 104 P*s-1 
(photo-isomerization rate) for at least 15 seconds. Light stimuli 
consisted of a series of 1-second bright flashes with 4-second 
intervals. Flashes evoked similar photo-isomerization rates in both 
medium and short wavelength cones. Flashes from the UV and Green 
LED had light intensity of 6.5·103 P*s-1/cone (Chapot et al., 2017). 
At these light levels, rods are expected to be saturated and therefore 
light-evoked responses should originate in cones and not in 
electrically coupled rods. To record Ca2+ levels and light-evoked Ca2+ 
responses in cone axon terminals, we captured image series (128 x 32 
pixels at 15.625), aligned with the outer plexiform layer (OPL) and 
covering an area of ~75 x 20 μm on the slice. We recorded both 
fluorescence channels as TN-XL allows ratiometric measurements 
via FRET between its fluorophores enhanced cyan fluorescent protein 
(ECFP, donor) and citrine (acceptor).  
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Pharmacology and drug application. All drugs were prepared as 
stock solutions in distilled water and were stored at 4°C. Before 
each experiment, drugs were freshly diluted from stock solution in 
carboxygenated ACSF solution. For bath application, the tissue was 
perfused with the drug added to the bathing solution for at least 1 
min before commencing the recording (perfusion rate of ~1.5 
ml/min). Rate of drug entry into the chamber was measured using 
sulforhodamine 101 (SR101) diffusion rates.  
 
Analysis of Ca2+ imaging data. All Ca2+ data was analyzed using 
custom scripts for IGOR Pro 6.3 (Wavemetrics). To extract cone Ca2+ 
signals, regions of interest (ROIs) were drawn manually around the 
cone terminals and the pixels within ROIs were averaged for each 
image frame. The relative Ca2+ level was then determined as the ratio 
between acceptor and donor fluorescence (FA/FD) signals after 
background subtraction. For each ROI, stimulus trials were averaged 
and the mean trace was filtered (box-car, 320 ms filter-width). 
Baseline Ca2+ level (Baseline) was defined as the mean prior to the 
light flash and we quantified the area between baseline and light 
response (area under the curve, AUC), and response amplitude 
(AMP). Previous studies showed that during retinal slicing, cells 
close to the surface might be mechanically damaged and show altered 
Ca2+ ratios (Wei et al., 2012). We tried to address this issue by 
recording from cones at least 20-50 μm into the slice and by excluding 
cones with unstable baseline and/or high noise level.  
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Calpain activity imaging using 2-photon microscopy. After slicing 
and mounting, retinal slices were incubated in a water bath @ 37°C 
for at least 2hrs in a modified calpain activity assay (CAA). Slices 
were incubated in calpain reaction buffer (CRB, as above) dissolved 
in ACSF. Since retinal slices were live tissue, non-denatured, no DTT 
was added to the solution. 50 µM Boc-Leu-Met-CMAC was added to 
the CRB-ACSF solution. After incubation, slices were moved to the 
imaging chamber of the two-photon setup where they were constantly 
perfused with the CAA buffer in ACSF with 20 µM Boc-Leu-Met-
CMAC with both the solution and chamber maintained at 37°C. 
Sections were scanned @860nm with 535 BP 50; 435 BP 40 (AHF, 
Tübingen, Germany) detecting the citrine signal from the TN-XL 
cones (used to locate cones and the ONL within the slice) and 435 BP 
40 (AHF, Tübingen, Germany) to detect the calpain signal. The 435 
BP 40 allows measurement of the fluorescently tagged calpain 
proteins while excluding the ECFP signal from the cones. Initially z-
stacks of the retinal tissue were recorded to determine the efficacy of 
the assay under the two-photon conditions. After initial imaging, one 
location was recorded over a more prolonged period. As the slicing 
may damage the tissue, all imaging was performed at a minimum 
depth of 20µm.  
Linear and multivariate linear modelling. We used a multivariate 
linear model to estimate the effect of drug application at different 
concentrations in retinal slice data. We used three measures for the 
outcome variable: the amplitude (AMP), area under the curve (AUC), 
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and baseline, and used our linear model to predict the effect of the 
treatment with a drug (Drug.y) and the concentration of the drug 
(Conc.y). 
y
AUC
 , y
AMP
, y
Baseline
 ~ f(xDrug,xConc) 
Separate linear models were fitted for each outcome variable. For 
each, a complete model including all fixed effects and interactions 
was fitted using maximum likelihood estimation (as implemented in 
R’s lmer package (Bates, Mächler, Bolker, & Walker, 2014). The 
significance of each effect and interaction was then evaluated using 
ANOVA. Effects and interactions whose significance were greater 
than p < 0.05 were retained in the final model for each outcome 
variable. The final models were as follows:  
 
y
AUC-Drug
 ~ a1.xDrug+a2.xConc+a3.xAUC-ctrl+a4.xAUC-ctrl+Drug  
+a5.xAUC-ctrl+conc+a6.xAUC-ctrl+Drug+conc 
y
AMP-Drug
 ~ a1.xDrug+a2.xConc+a3.xAMP-ctrla4.xAMP-ctrl+Drug  
+a5.xAMP-ctrl+conc+a6.xAMP-ctrl+Drug+conc 
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y
Baseline-Drug
 ~ a1.xDrug+a2.xConc+a3.xBaseline-ctrla4.xBaseline-ctrl+Drug  
+a5.xBaseline-ctrl+conc+a6.xBaseline-ctrl+Drug+conc 
 
The model was used to test the effect of each parameter to the 
responses by seeing which combination of factors more accurately 
mimicked the live cell recording data.  
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Results 
The rd1 and rd10 lines share mutations in the Pde6b gene, whereas 
the cpfl1 line suffers from a mutation in the homologous, cone-
specific Pde6c gene. To align our experiments with earlier studies of 
mouse PR degeneration, we first compared changes in ONL thickness 
over the first post-natal month between the three mutants and wt mice 
(Fig. 9). The ONL thickness dramatically decreases in post-P13 rd1 
and in rd10 after P18, illustrating the difference in onset PR cell death 
seen between these mouse models (Arango-Gonzalez et al., 2014). 
The rd10 degeneration is also somewhat less aggressive than rd1 as 
it takes longer for complete ablation of the ONL in rd10 than in rd1. 
In contrast, ONL thickness is not dramatically different between the 
cone degeneration mutant cpfl1 and wt, likely because in mice, rods 
outnumber cones approximately 20:1, such that the loss of cones is 
hardly noticeable in terms of overall ONL thickness. 
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Figure 9. Photoreceptor degeneration-related cell loss in different 
mouse lines. Cell loss was measured using outer nuclear layer (ONL) 
thickness during the first post-natal month in rd1 (cherry), rd10 
(amber), cpfl1 (lilac), and wild-type (wt, emerald) mice (n=3 animals 
per mouse line and time-point). 
Calpain activity increases in ONL of degenerating retina  
Having set the timeframe and extent of cell loss in the mutant models, 
we next aimed at elucidating the role of Ca2+ dysregulation in PR cell 
death. To this end, we focussed first on the activity and regulation of 
the Ca²⁺-dependent calpain-type proteases, among which are 
isoforms that are considered to be a suitable surrogate markers for 
Ca²⁺ dysregulation (Croall & Ersfeld, 2007; Darrel E Goll et al., 
2003). Moreover, calpain activity can easily be assayed in unfixed 
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retinal sections (Francois Paquet‐Durand et al., 2006). We examined 
calpain activity across the retina of RD mutant vs. wt retina (Fig. 10).  
Figure 10. Temporal progression of calpain activity in different 
mouse lines. A-C, representative images of sections from rd1 (A), 
rd10 (B), and cpfl1 (C) analysed with the calpain assay; each image 
of a mutant retina (right) is aged-matched with a wt control (left). D, 
normalised number of fluorescent cells in the ONL (per 1,000 µm2), 
indicative of calpain activity in PRs, as a function of age (n=45 
observations obtained on 3 animals per mouse line and time-point). 
Statistical analysis was Kruskal–Wallis one-way analysis of variance, 
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statistical significance is *** ≤ 0.001 unless otherwise stated. Scale 
bar: A-C, 50 µm. 
In rd1 retina, the number of ONL cells showing increased calpain 
activity was significantly higher compared to wt and cpfl1, at all time-
points, with a peak of activity at P12 (Fig. 10A, D; for detailed 
statistics of all comparisons, see Table 3). Calpain activity in rd10 
ONL was also significantly increased compared to wt and cpfl1 (at 
P18, 24, and 30), peaking around P18 (Fig. 10B, D). Also, in cpfl1, 
calpain activity tended to be higher than in wt, although without a 
clear peak within the inspected time frame (Fig. 10C, D). Overall, rd1 
retina displayed the highest levels of calpain activity. These data are 
largely in line with (Arango-Gonzalez et al., 2014; Francois Paquet‐
Durand et al., 2006) who showed increases in calpain activity at 
specific time points in models of RP and achromatopsia (see 
Discussion).  
Activation of calpain-2, but not calpain-1, increases during disease 
progression 
We then investigated whether the high levels of calpain activity 
observed in the ONL could be attributed to specific calpain isoforms. 
While 15 different calpain isoforms have been identified (Nemova, 
Lysenko, & Kantserova, 2010), we focussed on calpain-1 and -2, 
which are reported to be ubiquitously expressed in all mammalian 
cells and have been generally reported to play opposite roles in 
neurodegeneration (L. Y. Chen, et al.,  2007; Goñi-Oliver, et al., 
2007). We hypothesized that calpain-2 may contribute to the observed 
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increased calpain activity as it requires high [Ca2+] that are considered 
beyond the physiological range of PRs (D E Goll, 1995). Using 
antibodies recognizing the activated proteases, we found significantly 
increased numbers of calpain-2 positive cells in both rd1 and rd10 
ONL, when compared to cpfl1, as well as to wt controls (Fig. 11A, B, 
D; for all statistics, see Table 3). The peaks appeared to coincide with 
those for the calpain assay, namely at P12 (rd1) and at P18 (rd10). In 
cpfl1, the number of calpain-2 positive cells was slightly increased 
over the wt level (Fig. 11C, D), although without a clear peak. 
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Figure 11. Calpain-2 becomes activated during photoreceptor 
degeneration. A-C, representative images of sections from rd1 (A), 
rd10 (B), and cpfl1 (C) analysed for calpain-2 immunoreactivity; each 
image of a mutant retina (right) is aged-matched with a wt control 
(left). D, normalised number of fluorescent cells in the ONL (per 
1,000 µm2), indicative of calpain-2 immunoreactive PRs, as a 
function of age (n=45 observations obtained on 3 animals per mouse 
line and time-point). Statistical analysis was Kruskal–Wallis one-way 
analysis of variance, statistical significance is *** ≤ 0.001 unless 
otherwise stated. Scale bar: A-C, 50 µm 
 
To our surprise, a significant increase in calpain-1 positive cell 
numbers from wt level was only observed in rd10 (Fig. 12A-C). 
Calpain-1 labelling increased over background levels around P18 and 
was even more pronounced at the end of the observed time window 
(P30) (Fig. 12D). Next to rd10, only rd1 showed a detectable (but 
much lower and not significant) increase in calpain-1 positive cell 
counts.  
Taken together, we found a differential pattern of calpain isoform 
activation. While calpain-2 was strongly activated in rd1 and rd10 – 
and much less so in cpfl1 – calpain-1 appeared more strongly 
activated in rd10 compared to the other lines. In addition, the peaks 
of calpain-2 expression and of the calpain activity assay data coincide 
and precede that of calpain-1.  
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Figure 12. Calpain-1. A-C, representative images of sections from 
rd1 (A), rd10 (B), and cpfl1 (C) analysed with the calpain-1 
positivity; each image of a mutant retina (right) is aged-matched with 
a wt control (left). D, normalised number of fluorescent cells in the 
ONL (per 1,000 µm2), indicative of calpain-1 immunoreactive PRs, 
as a function of age. Statistical analysis was performed using 
Kruskal–Wallis one-way analysis of variance, statistical significance 
is *** ≤ 0.001 unless otherwise stated. Scale bar: A-C, 50 µm   
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Cell death coincides with calpain activity 
To quantify the levels of cell death and compare them to those of the 
activity and expression of calpain in the ONL, we used the TUNEL 
assay which labels dying cells. In agreement with earlier work 
(Arango-Gonzalez et al., 2014), we found significantly increased 
numbers of TUNEL positive cells in the ONL of the rd1 and rd10 
mice (Fig. 13A, B, D: for all statistics, see Table 3). An increase in 
TUNEL-positive cell number was also seen in the cpfl1 mouse (Fig. 
13C, D) albeit at a much lower level and with no discernible peak. 
The peaks in TUNEL-positive ONL cell numbers of rd1 (P12) and 
rd10 (P24) coincided temporally with those of calpain activity and 
calpain-2 labelling in the respective lines. TUNEL labels nick-ends 
in a cell’s DNA and while this makes it an excellent marker for cell 
death, it is non-specific to the actual cell death mechanism (Kraupp 
et al., 1995) .  
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Figure 13. Temporal progression of cell death. A-C, representative 
images of sections from rd1 (A), rd10 (B), and cpfl1 (C) analysed 
with the TUNEL assay; each image of a mutant retina (right) is aged-
matched with a wt control (left). D, normalised number of fluorescent 
cells in the ONL (per 1,000 µm2), indicative of TUNEL positivity in 
PRs, as a function of age (n=45 observations obtained on 3 animals 
per mouse line and time-point). Statistical analysis was Kruskal–
Wallis one-way analysis of variance, statistical significance is *** 
≤ 0.001 unless otherwise stated. Scale bar: A-C, 50 µm. 
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AIF and caspase-3 levels argue against classical apoptosis in 
degenerating rods  
How high intracellular [Ca2+] due to Ca²⁺ dysregulation is linked to 
PR cell death is still unclear. Prominent candidates for Ca2+-
dependent downstream pathways are apoptotic cell death through 
caspase effectors (Orrenius et al., 2003) and non-apoptotic cell death 
involving calpain activation (Arango-Gonzalez et al., 2014; Doonan 
et al., 2005; reviewed in Liu et al., 2004). To distinguish between 
these two proposed pathways, we used antibodies for cleaved 
caspase-3, a marker for apoptosis, and truncated AIF, seen as a 
marker for programmed necrosis (Arango-Gonzalez et al., 2014; S. 
Wang et al., 2018).  
AIF-positive cells were observed in the ONL of all disease models 
(Fig. 14A-D). Significant increases in AIF-positive cell numbers in 
rd10 occurred at the same time point (P18; for all statistics, see Table 
3) as those of TUNEL and calpain activity. This was not the case for 
rd1, where a significant increase in AIF-positive cell numbers was 
not seen until late in the investigated time window (P30). In addition, 
a small, non-significant increase in AIF-positive cells number was 
seen in cpfl1 retina.  
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Figure 14. AIF. A-C, representative images of sections from rd1 (A), 
rd10 (B), and cpfl1 (C) analysed with the AIF immunofluorescence; 
each image of a mutant retina (right) is aged-matched with a wt 
control (left). D, normalised number of fluorescent cells in the ONL 
(per 1,000 µm2), indicative of AIF immunoreactive PRs, as a function 
of age (n=45 observations obtained on 3 animals per mouse line and 
time-point). Statistical analysis was Kruskal–Wallis one-way analysis 
of variance, statistical significance is *** ≤ 0.001 unless otherwise 
stated. Scale bar: A-C, 50 µm. 
Increases in the numbers of cells showing caspase-3 activation were 
observed in all mouse lines (Fig. 15A-C) although to a low level (Fig. 
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15 D) and not at all time points (for all statistics, see Table 3). 
Significantly higher numbers of caspase-3 positive cells were seen in 
rd1 retina from P18 on, peaking at P24. The increases in the levels of 
caspase-3 positive cells were not seen to the same extent in the rd10 
as in the rd1. Modest increases were seen in the rd10 (for all statistics, 
see Table 3) comparable to those of cpfl1. 
 
 
83 
 
Figure 15. Activated caspase-3. A-C, representative images of 
sections from rd1 (A), rd10 (B), and cpfl1 (C) stained with an 
antibody against activated caspase-3; each image of a mutant retina 
(right) is aged-matched with a wt control (left). D, normalised number 
of fluorescent cells in the ONL (per 1,000 µm2), indicative of PRs 
with activated caspase-3, as a function of age (n=45 observations 
obtained on 3 animals per mouse line and time-point). Statistical 
analysis was Kruskal–Wallis one-way analysis of variance, statistical 
significance is *** ≤ 0.001 unless otherwise stated. Scale bar: A-C, 
50 µm. 
Upon further inspection, we noticed that in the rd1 retina, caspase-3 
positive cells were often overlapping with cones, as marked by the 
TN-XL biosensor. When we then analysed for rd1 cones expressing 
caspase-3, we found that at P24 a substantial number of cones were 
positive for activated caspase-3 (Fig. 16A-D).  
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Figure 16. Activated caspase-3 in cones. A-D, representative images 
of sections from rd1 P24 showing DAPI (A), cones (B), caspase-3 
(C) and a merged imaged of caspase-3 and cones (D). E, normalised 
number of fluorescent cells in the ONL (per 100 µm), indicative of 
cones in the wt retina (violet), cones not showing caspase-3 activation 
in rd1 (green), cones with activated caspase-3 (yellow) and caspase-
3 positive cells that were not cones (red; n=45 observations obtained 
on 3 animals per mouse line and time-point). 778 cones that remained 
in the 45 images, 111 of them (14%) were also positive for caspase-
3. Scale bar: A-D, 50 µm. 
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Gaussian process models infer probabilistic sequences of marker 
In the experiments so far, we noticed that the distribution of data 
points for a certain time point was often quite broad and featured 
multiple peaks (e.g. Fig. 10D, rd1 at P12; Fig. 11D, rd10 at P24). 
Possible explanations for this are variability between individual mice 
and variability of degeneration state across the retina. We tested the 
latter by resolving the distributions of the markers along the retinas’ 
dorso-ventral axis for all time points and mouse lines (Fig. 17). To 
this end, we collapsed data points along the naso-temporal axis, thus 
calculating the mean distribution along the dorso-ventral for each 
time point and visualized the whole time series as “spatio-temporal” 
heat maps (for original maps, see Figs. 18-23). 
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Figure 17. Summary heat maps illustrating the spatio-temporal 
progression of cell death markers, with image position along the y-
axis (dorso-ventral) and time along x-axis (see Methods for details 
and Supplemental Figures 3-8 for individual maps). Each element in 
the heat map is the mean value averaged over the naso-temporal axis. 
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Colours represent number of fluorescent cells in the ONL (per 1,000 
µm2) of calpain-1, calpain-2, calpain activity, AIF, caspase-3, and 
TUNEL. Note the scaling may be different for different markers.  
The spatial analysis revealed that degeneration did not occur 
uniformly across the retina of a given time point. For instance, in rd1 
animals, the peak in calpain activity at P12 first occurs in the central 
retina, and then at P14 in the peripheral retina (Fig. 18, 2nd row). This 
sequence is also visible in the spatio-temporal maps of rd1 for calpain 
activity, TUNEL, and calpain-2 (Fig. 17, 2nd column). A similar trend, 
though somewhat less clear, was observed in rd10 retina (Fig. 17, 3rd 
column; Figs. 18-23, 3rd row). Therefore, this spatial inhomogeneity 
of cell death markers for a given time point at least partially explains 
the aforementioned broad distribution of the data points (cf. Figs. 10-
15). 
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Figure 18. Heat maps for the spatio-temporal progression of calpain 
activity across the retina and for different mouse lines. Each map 
represents a time point, the grey disk the position of the optic nerve 
head (map origin). Each box in a map measures 1,000 µm by 400 µm, 
with the colour encoding the average number of fluorescent cells in 
the ONL (per 1,000 µm2). Grey areas denote areas that were not 
examined.  
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Figure 19. Heat maps for the spatio-temporal progression of cell 
death (TUNEL) across the retina and for different mouse lines. Each 
map represents a time point, the grey disk the position of the optic 
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nerve head (map origin). Each box in a map measures 1,000 µm by 
400 µm, with the colour encoding the average number of TUNEL 
positive cells in the ONL (per 1,000 µm2). Grey areas denote areas 
that were not examined. 
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Figure 20. Heat maps for the spatio-temporal progression of calpain-
2 activity across the retina and for different mouse lines. Each map 
represents a time point, the grey disk the position of the optic nerve 
head (map origin). Each box in a map measures 1,000 µm by 400 µm, 
with the colour encoding the average number of fluorescent cells in 
the ONL (per 1,000 µm2). Grey areas denote areas that were not 
examined.   
92 
 
 
Figure 21. Heat maps for the spatio-temporal progression of AIF 
activity across the retina and for different mouse lines. Each map 
represents a time point, the grey disk the position of the optic nerve 
head (map origin). Each box in a map measures 1,000 µm by 400 µm, 
with the colour encoding the average number of fluorescent cells in 
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the ONL (per 1,000 µm2). Grey areas denote areas that were not 
examined.  
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Figure 22. Heat maps for the spatio-temporal progression of calpain-
1 across the retina and for different mouse lines. Each map represents 
a time point, the grey disk the position of the optic nerve head (map 
origin). Each box in a map measures 1,000 µm by 400 µm, with the 
colour encoding the average number of fluorescent cells in the ONL 
(per 1,000 µm2). Grey areas denote areas that were not examined.  
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Figure 23. Heat maps for the spatio-temporal progression of caspase-
3 activity across the retina and for different mouse lines. Each map 
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represents a time point, the grey disk the position of the optic nerve 
head (map origin). Each box in a map measures 1,000 µm by 400 µm, 
with the colour encoding the average number of fluorescent cells in 
the ONL (per 1,000 µm2). Grey areas denote areas that were not 
examined. 
When comparing the spatio-temporal heat maps for different markers, 
we noticed that markers within the same retinal region appear in a 
certain temporal sequence that differs and/or is delayed between 
mouse lines. For example, in rd1 central retina, the peaks of calpain-
2, calpain activity, and TUNEL appear to coincide (~P12), followed 
by smaller peaks of caspase-3 (P24) and AIF (P30 or later). In rd10, 
the broader “peaks” of calpain-2, calpain activity, and TUNEL also 
coincide, yet are more spread out (from P18 to P30) and – different 
to rd1 – are associated with minor elevations of AIF- and calpain-1, 
but less caspase-3. 
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To more quantitatively identify the time points at which each cell 
death marker peaked in each mouse line, we fitted a set of Gaussian 
process models (Fig. 24; for details, see Methods). These models infer 
the mean and standard deviation of the number of labelled ONL cells 
over time. To estimate the time at which each marker peaked, we 
drew 10,000 samples from the posterior of each fitted Gaussian 
process model and identified the maxima in each sample. 
 
Figure 24. Gaussian process model for the kinetics of in cell death 
related processes. A, Parameters associated with photoreceptor cell 
A 
B 
C 
D 
wt rd1 rd10 cpfl1 
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death as measured in the ONL (per 1,000 µm2). B, Gaussian Process 
(GP) models with radial basis function kernel and additive Gaussian 
noise, fitted to observations to each cross of marker and mouse line. 
Observations are square root transformed prior to fitting, and after 
fitting are squared to return the model to its original state. 5% and 
95% confidence intervals are estimated using a bootstrap of 1k 
posterior samples, excluding the additive likelihood noise. C, 100 of 
the 1k posterior samples from the GPs. D, Density of the maxima of 
the GP posterior samples for each marker. 
The distribution of these maxima indicated the likely peak of each 
marker (Fig. 25). From these distributions, we identified the 
sequences of molecular markers which occurred in at least 5% of 
samples (Fig. 25). 
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Figure 25. Estimation of marker sequences, using probabilistic 
Gaussian Process bootstrap. Marker sequences from probabilistic 
Gaussian Process bootstrap where the probability of observing the 
sequence was estimated to be greater than 0.05. Probabilities 
estimated from 1,000 samples for each marker, in each mouse line. 
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In rd1, increased calpain activity, calpain-2, and TUNEL-positive 
cells tended to occur first in the sequence, while AIF and calpain-1 
were predicted to always be the last two markers (Fig. 25). In rd10 no 
sequence had a probability greater than 0.05 (Fig. 26). In wt mice, 
calpain activity preceded calpain-2 followed by TUNEL and calpain-
1, while in cpfl1, AIF was predicted to precede calpain-1 before 
TUNEL, calpain-2, and calpain activity. The overall levels of all 
markers were low for data obtained from wt and cpfl1animals, 
causing a relatively low level of confidence in the model predictions.   
 
Figure 26. Probability of each prediction. Sequence is defined to be 
the expected order of the peaks for each marker from probabilistic 
Gaussian Process bootstrap. The probability of each prediction for the 
order of markers is shown for each mouse line.  
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Differential effects of diltiazem enantiomers on cone baseline Ca2+  
Having investigated the activity and expression of calpain throughout 
the cell, we next set out to elucidate Ca²⁺ dynamics within the cell. 
As noted above, Ca²⁺ is responsible for the activation of calpain and 
so dysregulation of Ca²⁺ leads to increases in calpain activation. 
[Ca²⁺] within the cell are maintained by Ca²⁺ channels on the plasma 
membrane, allowing extracellular Ca²⁺ into the cell in a regulated 
manner. As mutations in Pde6 lead to CNGCs being kept open, Ca²⁺ 
channel blockers that could rebalance [Ca²⁺] are an attractive target 
for slowing or possibly ceasing the progression of the degeneration. 
While CNGCs are the channels affected by the Pde6 mutations they 
are not the only Ca²⁺ channels in the PRs, as VGCCs are located on 
several cellular compartments (see Introduction). To selectively block 
VGCCs, we used D-cis diltiazem (D-cis, selectively targets VGCCs; 
Glossmann et al., 1987) while an enantiomer L-cis diltiazem was used 
to target CNGCs (L-cis;  Koch & Kaupp, 1985). We first measured 
Ca²⁺ dynamics in wild type cones expressing the TN-XL biosensor. 
Once these dynamics were established, we then treated the cells with 
D-cis or L-cis to explore how selective inhibition of cellular Ca²⁺ 
entry affected the Ca²⁺ responses to light. As CNGCs are located on 
the outer segment, and VGCCs are located on the cell bodies and cone 
terminals, this strategy would tell us what effect, if any, handicapping 
the initiation, or completion of the phototransduction signal would 
have. To analyse the Ca²⁺ response, we examined three separate parts 
of it: the baseline (the starting level of Ca²⁺ within the cell before 
presentation with light), the amplitude (AMP, the maximum drop in 
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cellular [Ca²⁺] achieved by the cell from the baseline after being 
presented with light), and area under the curve (AUC, the area under 
the curve created by the exit of Ca²⁺ from the cell upon presentation 
with light, before the Ca²⁺ levels return to baseline levels), all with 
and without drug treatment.  
We saw that L-cis treatment showed a marked decrease in both the 
AMP and the AUC at 100 µM (Fig 27A, B). The effect of the L-cis 
on both AUC and AMP was concentration dependent as reductions 
were seen at 25 and 50 µM with the reduction becoming more 
pronounced with increases in concentration (Fig. 27A, B). No 
decrease was seen in either the AMP or the AUC upon treatment with 
D-cis with any concentration. Decreases in the baseline were seen 
with both the L-cis and D-cis treated cells while L-cis had a slight 
concentration dependent decrease that was not seen in the D-cis group 
(Fig. 27D). These decreases in baseline Ca2+ we similar to those seen 
between two control recordings (Fig. 27C) implying that the 
decreases may be more due to the recording conditions than the drug 
application.  
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Figure 27. Effect of drug on cone Ca2+ response. Scatter plot with 
predictions from a mixed model, showing mean predictions and 
standard errors for both L- cis- and D- cis- diltiazem at 25 (peach), 50 
(orange) and 100 µM (scarlet) for the amplitude (AMP, A), and area 
under the curve (AUC, B). Scatter plot for the drop in baseline Ca2+ 
levels between two control recordings (C). Scatter plot with 
predictions from a mixed model, showing mean predictions and 
standard errors for both L- cis- and D- cis- diltiazem at 25 (peach), 50 
(orange) and 100 µM (scarlet) baseline (D) with the drop in baseline 
Ca2+ seen in C overlaid. Multivariate linear model (E) predicting the 
explanatory power to the degree in which it improved model 
performance and importance of each factor and slope of the intercept 
of the mean response seen in A, B and D. Each parameter is combined 
with each other parameter to investigate which factor or group of 
factors is best at modelling the values seen in A, B and D. Statistical 
analysis is calculated using ANOVA with a numerical limiter below 
which values cannot drop * ≤ 0.05, *** ≤ 0.001.  
 
The effects of each factor were then evaluated in a multivariate linear 
model (Fig. 27D). This suggested that the state of the cell under 
control conditions (Baseline.x, AUC.x, and AMP.x) is highly 
significant for determining the state of the cell after treatment. This 
modelling also suggested that the state of the cell pre-treatment (i.e. 
whether it is responsive or not) in combination with the drug used 
(which enantiomer was applied) was also highly significant. This can 
be seen in Fig 27A and B, as in order for the drug to have an effect 
the cell must first be responsive. We then must know which 
enantiomer was applied as, L-cis caused a reduction in the light 
induced Ca²⁺ response, while D-cis did not. The third most significant 
factor when modelling the response was the pre-treatment state of the 
cell with the drug used and the concentration of drug used. Again, this 
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can be seen from Fig. 27A and B where L-cis reduced the Ca²⁺ 
response in a concentration dependent manner while D-cis did not. 
As seen in Fig 27, and confirmed by modelling, the particular drug 
used is also a significant indicator of the effect on the AMP and AUC, 
though not on baseline.  
Taken together, our data and modelling suggest that L-cis diltiazem 
impacts phototransduction more strongly than D-cis diltiazem, as 
measured by the AMP and AUC. Drops in the baseline [Ca2+] seen 
upon application of both enantiomers is similar to that with no drug 
applied. Modelling suggests that to recreate the data the initial 
responsiveness of the cell is of vital importance, followed in 
importance by the combination of the responsiveness, drug used, and 
concentration of the drug. Initial responsiveness and drug used were 
also found to be significant for all three criteria tests, while knowing 
the drug that was used was significant for AMP and AUC. Having 
seen the effect of these drugs on the Ca²⁺ dynamics within the cell, 
we next moved to see how treatment with these drugs effected the 
activity of calpain within PRs. 
 
Different diltiazem enantiomers have opposite effects on calpain 
activity  
Previous work from our lab has shown that treatment of retinal 
cultures with L-cis or D-cis diltiazem has a variety of effects on the 
levels of cell death seen in the ONL (Soumyaparna Das, 
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unpublished). Treatment with 100 µM L-cis diltiazem showed a 
decrease in the level of cell death in the rd1 mutant model but an 
increase in the level of cell death in the wt control. Conversely, 100 
µM D-cis diltiazem treatment resulted in an increase in the level of 
cell death in the mutant mouse but a decrease in the levels of cell 
death in the wt (Das, unpublished). 
To investigate how diltiazem treatment effected calpain activity, we 
used cultured rd1 or wt explants and applied either 100 µM of L-cis 
or D-cis diltiazem and compared with a non-treated control for each. 
Treatment with L-cis resulted in a dramatic reduction in calpain 
activity in the cultured rd1 retinas but a noticeable increase in the 
activity of calpain in the wt compared to untreated condition (Fig. 28). 
Treatment of cultures with D-cis showed a reduction in the calpain 
activity of rd1 treated mice compared to untreated controls and a 
marked reduction in the calpain activity in the wt treated retinas 
compared to untreated controls (Fig 28). These results largely agreed 
with data previously produced in our lab by Soumyaparna Das 
examining the effect of diltiazem on cell death (unpublished). The 
difference between these two studies is the increase in cell death seen 
in rd1 treated with D-cis compared to a decrease in calpain activity 
seen under these same conditions. To allow us to investigate real time 
Ca²⁺ imaging with its effect on cellular protein, we next moved to 
develop a method to image calpain activity under two-photon 
conditions.  
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Figure 28. Diltiazem treatment on calpain activity. A, B, 
representative images of sections from rd1 and wt treated and 
untreated with L-cis diltiazem (A) or D-cis diltiazem (B) analysed 
with the calpain assay; each image of an untreated control retina (left) 
is matched with a treated retina (right). C, normalised number of 
fluorescent cells in the ONL (per 1,000 µm2), indicative of calpain 
activity in photoreceptors, as a function of treatment. Statistical 
analysis was two-way ANOVA with Bonferroni posthoc statistical 
significance: *** ≥ 0.001; * ≥ 0.05 unless otherwise stated. Scale bar: 
A, B is 50 µm 
 
 
Imaging of calpain activity using two-photon microscopy 
We adapted the protocol originally used to detect calpain activity ex 
vivo, using unfixed tissue sections and widefield fluorescence 
microscopy (Paquet-Durand et al., 2006), to be used in vitro, on live 
retina slices under a two-photon microscope. Using this new protocol, 
we readily detected calpain activity in the plasma membrane of both 
wt and rd1 PRs (Fig. 29), in agreement with the membranous 
localization of different calpain isoforms described previously 
(Paquet-Durand et al. 2006). In the ONL of the rd1 retina there were 
occasional cells that appeared to show higher calpain activity, 
however, their number was relatively low when compared to the 
number of calpain positive PRs seen in ex vivo preparations. Calpain 
activity was also seen in the INL and in retinal ganglion cells, in 
agreement with a similar increase observed in cultured retinas 
(François Paquet‐Durand, Johnson, & Ekström, 2007). This increase 
109 
 
in calpain activity in ganglion cells is probably triggered by severing 
of the optic nerve, which is common to both preparations.  
Under the in vitro imaging conditions described above, however, the 
calpain activity signal, in particular, the numbers of calpain activity 
positive cells, turned out to be rather low when compared to ex vivo 
preparations. To increase the cellular calpain activity signal, we then 
proceeded with incubating the retinal slices with the CAA and the 
Ca2+ ionophore ionomycin. While the addition of ionomycin did 
increase calpain activity in PRs, the in vitro staining was still weaker 
when compared to the ex vivo situation. With the addition of 
ionomycin the detection rate of calpain positive cells using the two-
photon microscope was approximately 12% of what was seen in the 
ONL of ex vivo preparations (Fig 30).  
Taken together, while calpain activity could be measured in living 
retina using two-photon microscopy, and while the results agree with 
previous findings on high calpain activity in the rd1 ONL, the 
sensitivity of detection under two-photon in vitro imaging was lower 
than that under ex vivo assay conditions. This reduction in signal to 
noise ratio is likely due to the osmolarity of the solution used to 
incubate the tissue, making it difficult to discern calpain positive cells 
from the background noise especially when compared to ex vivo 
imaging (see Discussion). 
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Figure 29. Two-photon imaging of calpain activity in wt and rd1 
retina. The TN-XL biosensor labels cones within the outer nuclear 
layer (ONL) in rd1 (A) and wt (E) retina. Calpain activity imaged in 
rd1 (B) and wt (F) retina. Merged images displaying cones (in green, 
C) and calpain activity (red, G). Note that that calpain activity was 
also observed in the inner retina, especially in the ganglion cell layer 
(GCL). Retinal calpain activity detected with the ex vivo assay is 
shown for rd1 (D) and wt (H), for comparison. Scale bar = 50 µm. 
INL, inner nuclear layer; IPL, inner plexiform layer. 
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Figure 30. Quantification of calpain activity positive cells. Within the 
ONL, cells positive for calpain activity were counted. The in vitro 2-
photon live imaging (n= 1 mouse, 16 images) situation was compared 
to in vitro imaging with the addition of ionomycin (n= 2 mice, 50 
images) as well as with the ex vivo situation ((n= 3 mice, 45 images) 
using unfixed retinal sections.  
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Calpain activity 
 Wild type rd1 rd10 cpfl1 
 Mice Images Mice Images Mice Images Mice Images 
P10 3 45 3 45 - - - - 
P12 3 44 3 45 - - - - 
P14 3 44 3 50 5 75 3 55 
P18 3 45 3 41 4 74 3 54 
P24 3 39 6 76 3 50 3 45 
P30 3 45 3 40 3 45 3 45 
P60 3 44 - - - - 3 43 
P90 3 32 - - - - 3 45 
P120 3 45 - - - - 3 45 
Calpain-2 
P10 3 45 3 45 - - - - 
P12 3 45 3 45 - - - - 
P14 3 45 3 44 3 45 3 45 
P18 3 45 3 45 3 44 3 45 
P24 3 45 3 45 3 45 3 45 
P30 3 45 3 45 3 45 3 45 
TUNEL 
P10 3 45 3 45 - - - - 
P12 3 45 3 45 - - - - 
P14 3 45 3 45 3 45 3 45 
P18 3 45 3 45 3 45 3 45 
P24 3 45 3 45 3 45 3 45 
P30 3 45 3 45 3 45 3 45 
AIF 
P10 3 45 3 45 - - - - 
P12 3 45 3 45 - - - - 
P14 3 44 3 40 3 45 3 45 
P18 3 45 3 45 3 45 3 44 
P24 3 45 3 45 3 45 3 45 
P30 3 45 3 45 3 45 3 45 
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Table 2. Number of mice used for each genotype, post-natal time-
point and marker as well as numbers of images recorded. 
 
 
 
 
 
 
 
 
Caspase-3 
P10 3 45 3 45 - - - - 
P12 3 45 3 45 - - - - 
P14 3 44 3 40 3 45 3 45 
P18 2 30 3 45 3 45 3 45 
P24 3 45 3 45 3 45 3 45 
P30 3 45 3 45 3 45 3 45 
Calpain-1 
P10 3 32 3 45 - - - - 
P12 3 39 3 44 - - - - 
P14 1 12 3 44 3 45 3 45 
P18 3 45 3 45 3 45 3 45 
P24 3 45 3 45 3 45 3 45 
P30 3 45 3 45 3 45 3 45 
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Calpain Activity 
 Wild type rd1 rd10 cpfl1 
P10 0.14±0.023 0.78±0.06
8 
- - 
P12 0.055±0.012 4.3±0.27 - - 
P14 0.053±0.007
4 
2.69±0.11 0.11±0.019 0.09±0.008 
P18 0.051±0.005
7 
1.19±0.13 1.36±0.145 0.08±0.01 
P24 0.0255±0.00
6 
1.001±0.1
3 
0.878±0.12
2 
0.15±0.01 
P30 0.06±0.02 0.74±0.12 0.82±0.068 0.12±0.01 
P60 0.044±0.005 - - 0.22±0.02 
P90 0.054±0.007 - - 0.176±0.02 
P12
0 
0.058±0.008 - - 0.21±0.016 
TUNEL 
P10 0.046±0.01 1.15±0.11
6 
- - 
P12 0.078±0.016 6.1±0.42 - - 
P14 0.156±0.011 3.63±0.18 0.17±0.12 0.16±0.017 
P18 0.14±0.011 2.94±0.3 1.76±0.23 0.21±0.019 
P24 0.086±0.013 1.44±0.14 2.7±0.16 0.19±0.01 
P30 0.03±0.0088 1.40±0.10
1 
1.08±0.08 0.1±0.02 
Calpain-2 
P10 0.034±0.006 0.46±0.05 - - 
P12 0±0.006 0.95±0.14 - - 
P14 0.026±0.006 1.10±0.13 0±0.01 0.016±0.004
9 
P18 0.019±0.005 0.3±0.033 0.41±0.09 0±0.003 
P24 0±0.007 0.26±0.07 0.29±0.05 0.024±0.003
8 
P30 0±0.003 0.19±0.08
8 
0.73±0.1 0±0.004 
Calpain-1 
P10 0±0 0±0 - - 
115 
 
Table 3: Median values plus/minus the standard error of the mean 
recorded from each mouse model at each time point and for each 
marker. 
 
 
 
 
 
 
 
P12 0±0.0035 0±0.0015 - - 
P14 0±0 0±0.002 0±0.002 0±0.0007 
P18 0±0.0007 0±0.0016 0±0.04 0±0.002 
P24 0±0.0004 0±0.004 0±0.025 0±0.0009 
P30 0±0.002 0±0.014 0.38±0.05 0±0.0009 
Caspase-3 
P10 0±0.00095 0±0 - - 
P12 0±0.00057 0±0 - - 
P14 0±0 0±0.004 0±0 0±0.0009 
P18 0±0 0±0.019 0±0.006 0±0.0004 
P24 0±0 0±0.045 0±0.007 0±0 
P30 0±0 0±0.008 0±0.001 0±0.0004 
AIF 
P10 0±0.0006 0±0.002 - - 
P12 0±0.001 0±0.0025 - - 
P14 0±0.003 0±0.0035 0±0.003 0±0.004 
P18 0±0.001 0±0.018 0.45±0.1 0±0.004 
P24 0±0.0007 0±0.027 0.91±0.091 0±0.0003 
P30 0±0.0023 0±0.085 0.65±0.08 0±0.0008 
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Discussion 
Here, we provide several lines of evidence on the role of calpain 
activity as a driver of PR degeneration and show that calpain-2, but 
not calpain-1, is likely implicated in PR cell death. AIF appears to be 
contributing to the primary rod PR death while caspase-3 does not. 
However, caspase-3 may be involved in secondary cone 
degeneration. These trends coincide temporally with peaks occurring 
at approximately the same time, but they also correlate with each 
other spatially, typically starting in the centre of the retina before 
spreading to the periphery. We also provide evidence that application 
of a CNGC blocker ablates light induced Ca²⁺ responses when 
blocking VGCCs does not.  
To discuss the role of calpain activity, we will consider the effects of 
energy metabolism; the interactions between calpain and caspase and 
suggestions for how to elucidate their interactions; the secondary 
cone death; the spatial occurrences of markers and progression of cell 
death; how calpain as a viable marker for Ca2+ based cellular distress; 
and lastly, the effect of Diltiazem on the retina. We will discuss the 
statistical and analytical approaches to time point selection, including 
calpain imaging under two-photon conditions before considering the 
impact of this research, its limitations and directions for the future.   
Effects of energy metabolism on Ca²⁺ dysregulation and cell death  
Ca²⁺ dysregulation occurs in PRs with PDE6 gene mutations, 
typically resulting in higher Ca²⁺ concentrations (Kulkarni et al., 
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2016). This rise in Ca²⁺ would lead to increased activity of the plasma 
membrane NCKX, an antiporter responsible for maintaining 
appropriate Ca²⁺ levels in PR outer segments (Jensen, Buckby, & 
Empson, 2004). NCKX is driven by a K+ gradient, which in turn is 
maintained by K+-ATPases. Elsewhere in the cell, low intracellular 
Ca2+ levels are ensured by specific Ca2+-ATPases that have the 
highest ATP affinity of all ATPases. This may explain why low Ca2+ 
can be maintained even when general cellular [ATP] is very low 
(Bruce, 2017).  
As necrosis is a passive process that does not require ATP, it has long 
been suspected that the levels of ATP in the cell are a determining 
factor for whether, under stress, the cell chooses apoptosis or necrosis 
to complete cell death (Criddle et al., 2007; Leist et al., 1997; 
Tsujimoto, 1997). It was theorised by Liu et al., (2004) that cells that 
have been cultured prefer apoptosis as a method of cell death, due to 
the availability of glucose in the media allowing for a ready 
production of ATP in the cell. This steady state of ATP production by 
cells being cultured would drive an injured cell towards apoptosis, 
something that should be considered were culturing necessary to fully 
elucidate any caspase and calpain activation in damaged cells. In our 
dataset, we saw high levels of calpain activity, especially high levels 
of calpain-2 activation. The high affinity of Ca2+-ATPases for ATP, 
combined with the high levels of Ca²⁺ required for the activation of 
calpain-2, would indicate that in dying PRs any remaining ATP had 
already been used up. 
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Thus, a cell death pathway not dependent on ATP (such as necrosis, 
although not necessarily necrosis) would seem to be the preferred 
pathway for the PRs to avail of, as seen by the increase in AIF staining 
in the ONL. This energy requirement would also explain why 
caspase-3 activation is only seen in later time points examined and 
predominantly in cone PRs. We do however, provide evidence that 
calpain activity is an early event and peaks with cell death in both rd1 
and rd10 models, but that levels of activity and regulation of harmful 
calpain isoforms (calpain-2) are low prior to the increase in cell death 
and rise in tandem with it. This rise in calpain activity and calpain-2 
activation would suggest that calpain, were it involved in cell death, 
would be part of a passive, ATP independent cell death mechanism. 
Calpain and caspase 
It is worth noting that there is a complex set of interactions between 
calpain and caspase. For instance, calpastatin, the natural inhibitor of 
calpains, is cleaved by caspase isoforms (Pörn-Ares, Samali, & 
Orrenius, 1998; K. K. W. Wang et al., 1998) suggesting a role for 
caspase in the activation of calpains. Calpain isoforms, however, also 
have a role in the inactivation of caspase molecules. It was shown in 
cultured monkey RPE cells that under hypoxic conditions, 
procaspase-3 was cleaved into inactive forms (Emi Nakajima et al., 
2017) by calpain, likely calpain-1 based on their western blotting 
results. These fragment sizes were shown to be unique to calpain 
cleavage by E Nakajima et al., (2014). These contradictions lead to 
more questions about the interaction between caspase and calpain 
119 
 
isoforms. It is possible that some caspase isoforms activate calpain-2 
through the cleavage of calpastatin. These caspase isoforms however, 
cannot execute the apoptosis pathway through the activation of 
executor caspases, as these have already been cleaved inactive by 
calpain-1. It is also possible that caspase isoforms are in fact activated 
by the dysregulation of Ca2+ through disruptions of the mitochondrial 
membrane, and are then cleaved by calpain-1, temporarily saving the 
cell until the persistent Ca2+ dysregulation leads to the activation of 
the calpain-2 and therefore the process of cell death continues, albeit 
through a different mechanism.  
Very fine temporal analysis and rigorous experimental conditions are 
needed to full elucidate these pathways as we will discuss here. As 
mentioned above, the energy state of the cell can be a large 
determining factor for which cell death pathway is utilised. A possible 
experiment to determine caspase-calpain interactions under various 
energy conditions would be to first tag the different caspase and 
calpain isoforms being investigated (here calpain-1, calpain-2 and 
caspase-3) with FRET based molecules, a donor FRET to caspase and 
an acceptor FRET moiety to the calpains. If the caspase-3 were to 
donate energy to the calpain-2 isoform before the calpain-1 isoform, 
one could tell by the colour of the tags being detected. It would also 
be possible to do this semi-continuously in a cell culture where the 
levels of the insult and glucose (as two possible parameters) could be 
tightly regulated probing the exact conditions each interaction took 
place under. As this would initially be done in cell culture the FRET 
linked proteins transfected into the cells and then moved to mouse 
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lines using transgenic mice. Highly regulated cell culture, or an 
inducible model of cell death within the retina, would be the preferred 
methods of elucidating these interactions as experimenters would 
have greater control over the timing of the intracellular events and not 
be constrained by heterogeneous cell death patterns.  
Regardless of the form of cell death taken by PRs with Pde6 
mutations, we are confident that the dysregulation of Ca2+ precipitates 
cell death. As the other PRs in the retina are unaffected by this 
mutation (rods in cpfl1 and cones in rd1 and rd10) it is unlikely that 
they would die from the same mechanism as that of the diseased PRs 
(as discussed below). It is therefore imperative that methods be 
developed that can rebalance Ca2+ regulation within injured PRs, be 
it through pharmacological interventions to target the channels, or 
pumps, or a gene therapy that would replace the non-functional 
mutated genes.  
It is notable that levels of calpain-1 appear abruptly in the rd10 but 
not in other mouse models. This may be a mechanism employed by 
the remaining PRs to try and survive. Calpain-1 has been implicated 
in more neuroprotective mechanisms, (discussed in Baudry & Bi, 
2016) and the different mutations between rd1 and rd10 and the 
somewhat slower progression of the rd10 degeneration may give the 
cells more time to activate such calpain-1 dependent neuroprotective 
processes.  
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Secondary cone death driven by apoptosis in rd1 
While the majority of rd1 rod PRs die between P12-P14, some cells 
(mostly cones) remain beyond P18. Interestingly, we did find that a 
substantial cohort of the remaining cones were positive for caspase-3 
in the rd1 mouse at P24. This would suggest that while the primary 
rod degeneration is non-apoptotic, secondary cone degeneration 
might well be an apoptotic process. Since apoptosis is a “clean” form 
of cell death for the tissue at large that does not cause inflammation 
or otherwise detrimental tissue reactions, it is often employed to 
remove stressed cells. The exact reason for this cell death (e.g. 
starvation, physical pressure by the RPE as the rods no longer provide 
structural support) is not clear from our data set, however. 
Another unknown is the stress that affects the cones causing them to 
enter the apoptotic cycle. The stress on the cones may be due to 
metabolic dysregulation or physical stress, or both at the same time. 
We see that the morphology of cones is affected by the degeneration 
(Fig. 16B) while detachment of the retina from the RPE, which is part 
of a delicate metabolic ecosystem along with the PRs and Mueller 
glial cells (Kanow et al., 2017) has also been observed in clinics 
(Ishida et al., 2013). At any rate, the more distal causes for the 
secondary degeneration are beyond the scope of our present 
investigation.  
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Spatial occurrences of markers, and progression of cell death 
Within the rd1 mouse retina a clear centre to periphery trend can be 
seen for calpain activity, calpain-2 up-regulation, and TUNEL. This 
suggests that the activity of calpain (likely calpain-2) drives the 
progression of cell death across the retina. The centre to periphery 
wave of cell death is well established and is theorised to follow cell 
maturation patterns in the rd1 mouse (Noell, 1958). Cell death 
patterns seen in the rd10 are less well known. In our examination, a 
centre to periphery gradient was seen for calpain activity, calpain-2 
and TUNEL in the rd10 mouse, although this gradient was not as 
distinct as that in the rd1 mouse. This could be due to time point 
selection or to the fact that the degeneration seen in the rd10 mouse 
is less homogeneous than that in the rd1 mouse. No pattern of marker 
up-regulation or activation was detectable in the cpfl1 mouse model 
as seen in the individual heat maps (Fig. 18-23). This is probably due 
to the low number of cones in the mouse retina and the stochastic 
nature of the cell death seen in all mouse models of retinal 
dystrophies.  
While some studies have investigated the expression patterns and cell 
death patterns across the retina (Schaefer et al., 2017), most studies 
focus their investigations on the area of the retina around the optic 
nerve. Our study builds on these and expands, showing that previous 
links between Ca2+, calpain, and cell death are not only present in 
populations of cells around the optic nerve, but throughout the retina. 
This shared link and the temporal order of the progression of the 
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disease is important to know as were the initial stages of the disease 
diagnosed, populations of cells, in the periphery in case of the mouse 
and in the fovea in the case of humans, could be saved through 
intervention. While the finding that rods throughout the rd1 and rd10 
retinas degenerate through similar pathways may seem obvious, it 
would have been just as easy to assume that cones in these retinas die 
through the same pathways as rods, which, we have evidence to 
suggest is not the case. Our study is also limited somewhat: we 
rigorously sampled values along the dorsal – ventral axis, often at the 
expense of the temporal – nasal axis, and we can only speculate 
whether there would be a differential pattern between the two axes 
had they been measured equally. Examining the markers across the 
whole eye in the nasal – temporal axis in the same manner might, for 
example, show a possible difference based on cone cell type, based 
on opsin expression (Baden et al., 2013) in the dorsal – ventral 
direction, which is not present on the nasal-temporal axis. This 
particular criterion would provide differences in examining the two 
axes, but as the mouse retina is so rod dominated, these differences 
would be slight and need untangling using cone specific markers.   
Different cell death mechanisms in Pde6b mutants? 
The differences seen between rd1 and rd10 may provide interesting 
insights into the causative degeneration mechanisms. While both 
models show high levels of calpain activity, calpain-2, and TUNEL, 
at ages corresponding to their respective peaks of degeneration (P12 
and P18, respectively), there may be differences in the mode of cell 
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death utilised by the PRs. AIF and calpain-1 activation are seen more 
in the ONL of the rd10 mouse while rd1 retina did not show these 
markers until relatively late (P24), at which point they may be located 
predominately to cones. This leads us to ask whether different 
mutations within the two models might cause different pathways of 
cell death. The fact that we saw a peak of TUNEL staining in rd1 
several days before we saw AIF or caspase-3 up-regulation indicates 
that neither can be responsible for the DNA cleavage, pointing 
towards other proteins.  
 
Calpain as a viable marker for Ca2+ based cellular distress 
Calpain is a well-documented Ca²⁺ activated cysteine protease. It has 
been long implicated in both necrotic and apoptotic events within the 
cell, as well as a variety of physiological functions. Calpains are a 
very interesting family of cellular proteases as, unlike other families 
(caspases), the different isoforms often have opposing functions 
(discussed in Baudry & Bi, 2016). Calpain’s dependence on Ca²⁺, 
along with its implicated role in cell death makes it an ideal candidate 
for our investigation, as it may well act as a stepping stone between 
Ca²⁺ dysregulation, especially in the case of calpain-2 and cell death. 
Calpain is a plasma membrane associated protein, meaning cellular 
damage does not need to occur in order for calpain to act on cellular 
structures. Within the relevant literature, the Ca²⁺ dysregulation 
linked to cell death is often mediated through damage to the 
mitochondrial membrane, thus releasing apoptotic molecules such as 
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Bcl-2, Bax, and Bac. Due to the variety of calpain functions, it is 
possible that by the time the mitochondria are damaged, due to 
possible overfilling with Ca²⁺ ions, calpain isoforms have already 
been autolysed, activated and have acted on a variety of substrates 
already eliciting detrimental effects on cell survival. It has been 
estimated that a Ca²⁺ ion migrates no further than 0.5µm and lasts no 
more than 50µs, before encountering a binding protein, based on the 
assumption an on equilibrium (kon of 108 M-1s-1 and a 300µM binding 
protein concentration) (Allbritton et al., 1992). The diffusion of Ca²⁺ 
is also a variable condition, dependant on the saturation of buffering 
stores and proteins. It is a non-uniform system, with buffering entities 
distributed in a function based, rather than a uniform, manner 
(Allbritton et al., 1992).  This restriction of Ca²⁺ diffusion would 
again indicate that calpain activation, as well as the binding of Ca²⁺ 
to all other membrane or cytosolic Ca²⁺ binding proteins, would 
precede mitochondrial saturation and damage, key requirements for 
the apoptotic cascade.   
The effect of Diltiazem on the retina 
The use of the Ca2+ channel blocker Diltiazem has been utilised by 
retinal researchers since 1999, when, Frasson et al. found it to delay 
rd1 mouse PR degeneration. However, follow up studies aiming to 
reproduce this finding to rescue PRs had mixed results. Several 
studies (Bush, Kononen, Machida, & Sieving, 2000; Pawlyk, Li, 
Scimeca, Sandberg, & Berson, 2002; Pearce-Kelling et al., 2001) 
have shown that use of the D-cis enantiomer had little effect on the 
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progression of disease in PRs with mutations resulting in RD. Other 
groups (Paquet-Durand et al., 2010) however have shown that the 
CNGCs (which can be targeted by the L-cis enantiomer of diltiazem) 
did show some improvement in degenerating retinas suggesting that 
this enantiomer may in fact be beneficial to PR survival.  
Our data suggests that calpain activity is decreased in ONL sections 
treated with D-cis diltiazem in both rd1 and wt mice. The treatment 
of ONL sections with L-cis results in a decrease of calpain activity in 
the ONL of rd1 mice but an increase in the levels of calpain activity 
in the ONL of wt mice. This data is conflicting for several reasons. 
The entry of Ca2+ into the outer segment of PRs is not only tightly 
regulated, but very strictly buffered (discussed in Krizaj & 
Copenhagen, 2002). The connecting cilium is thought to be a very 
efficient physical barrier of Ca2+ between the inner and outer 
segments, not allowing the movement of any remaining free Ca2+ 
between the two (Krizaj & Copenhagen, 1998). This buffering and 
segmentation of the PRs makes the interpretation of the L-cis treated 
sections difficult to interpret. As the decrease in Ca2+ cannot lead to 
an even distribution of lowered Ca2+ across the cell due to the 
buffering of the cell and stores, and the lowering of Ca2+ can only 
occur within the OS due to the distribution of CNG channels that L-
cis targets, the reduction in the activation of calpain needs to be 
further examined. Data produced in our lab (by Soumyaparna Das and 
Maria Pia Polito) shows that rod CNG channels are present in the 
truncated OSs of rods at P11 in both wt and rd1. At P11, mouse PRs 
are not yet fully matured and so the barrier function of the cilium may 
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not yet be fully functional. This would allow for a drop in the Ca2+ 
levels in the OS to affect the overall cellular [Ca2+], resulting in a drop 
in calpain activity. We see from our timelines that the level of calpain 
activity in the rd1 mouse is already significantly higher at P10, 
indicating that the dysregulation of these few CNG channels is 
already in progress. Determination of the buffering capacity of the 
cilium could be determined by immunohistochemistry examination if 
not direct examination with a Ca2+ sensor (Fura-2 or Oregon green 
BAPTA-1). The cilium is filled with Ca2+ binding proteins such as 
centrin, calmodulin kinesin II, and myosin VII (Marszalek et al., 
2000) and so antibodies for these proteins could be utilised to 
determine how developed the buffering capacity of the cilium is at 
various time points in both diseased and wt PRs.  
We see that L-cis, but not D-cis, diltiazem reduces the light induced 
Ca2+ response in cones under the two-photon microscope. The effect 
of L-cis diltiazem on the light induced Ca2+ response would suggest 
that when the CNGCs are blocked, hyperpolarisation is not achieved. 
Therefore, the light induced response is not propagated. The blockage 
of the VGCCs by the D-cis isoform did not seem to inhibit 
phototransduction as the light induced Ca2+ response was unaffected. 
As the treatment of retinal explant cultures with diltiazem does 
produce an effect both on calpain activity and cell death (Das, 
unpublished), we propose that D-cis diltiazem does have an effect on 
rods but perhaps not on cones. This differential effect may be due to 
the different VGCC isoforms on the two PR types (Cav 1.3 on cones 
and Cav 1.4 on rods; Morgans et al., 2005) and the difference in 
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subtypes in the CNGCs. Little has been written about how diltiazem 
achieves its blockage of Ca2+ channels on the cells, or indeed the 
affinity of the channels for the particular isoform.  
It was noted by Lee & Tsien, (1983) that the number of channels left 
unblocked increases in tandem with increases in the extracellular 
[Ca2+]. Yet, the fact that D-cis diltiazem has a pronounced effect on 
calpain activity in sectioned retinal explant cultures suggests that D-
cis affects rods, even if no effect on cones has been seen here. There 
may also be a timing and access issue: L-cis may be better at binding 
to the channel or may be given better access to the channels on the 
OSs as the OSs are solution facing in both protocols. The D-cis by 
comparison has further to travel through the tissue and in culture 
conditions has more time to reach the channels. We checked how fast 
the perfusion chamber filled with a drug solution by substituting 
ACSF for sulforhodamine and measuring how long it took to saturate 
the chamber. During the experiments both diltiazem enantiomers 
were given the same amount of time to affect the Ca2+ response. D-
cis may need more time than this to be effective however, and so more 
chronic recordings (one-minute recording followed by a minute to 
allow the cell recovery time repeated n number of times) would allow 
us to disentangle this somewhat.   
An issue with the interpretation of the diltiazem treated cultures data 
is the spatial element. Due to the increased difficulty in maintaining 
spatial orientation during the mounting of the retina to the membrane, 
in combination with the loss of large portions of the tissue during 
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slicing, we can ascertain that the tissue stained and imaged was from 
the medial portion of both rd1 and wt. We see from our heat maps 
that the levels of calpain activity in both rd1 and wt are increased in 
the very medial portions of the retina before the increase is seen in 
the periphery. This unknown spatial distribution of the cultured 
retinal sections imaged could be the reason an increase in calpain 
activity is seen in the wt after the treatment with L-cis diltiazem. As 
we see from the heat maps, a difference of 400µm could give higher 
or lower values. The difference between the treated and untreated wt 
sections treated with L-cis is ~0.25 active cells in the ONL per 
1,000µm2. As we do not know where in the retina these sections were 
taken from, a slight shift in the location imaged between the two drug 
treatments could account for the variation.  
Statistical and analysis approaches to time point selection 
We extensively investigated several time points in mouse models of 
RD. Some of these time points, such as P10 and P12, fill in previously 
underexplored time points, while others, such as P18 and P30, were 
well examined time points in previous studies (Arango-Gonzalez et 
al., 2014). Our data indicates that some of these time points may have 
been over sampled. Some instances, such as the values at P12 in the 
calpain-2, calpain activity and TUNEL timelines are hard to justify 
using fewer animals. The variability in the values seen in the above 
data sets was only explained by further analysis into the spatial 
distribution without which the distribution of the data would have 
been treated sceptically. This in itself points to an important issue in 
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our investigation. We added to previous work (Arango-Gonzalez et 
al., 2014) by adopting an experimental strategy that emphasised the 
use of large numbers of samples at a small number of predetermined 
time points (Kulkarni et al., 2016). Although this approach was useful 
for inferring the state of the system at particular stages of disease 
progression, the rigidity of the sampling came at the cost of lower 
temporal resolution.  
For future work, where the temporal precision is critical, it would be 
preferable to adopt an adaptive strategy, using the GP models to select 
the optimal time points for particular hypotheses (Chaloner & 
Verdinelli, 1995; Lindley, 1956). This should make it possible to infer 
more accurately the non-linear progression of each marker over time, 
with fewer samples than would be needed in a predetermined or 
purely random approach. Follow-up studies would benefit from an 
adaptive strategy, using the GP models to identify time points of 
interest as data is acquired. This might also include testing the 
expression of further degeneration markers throughout the eye. 
Calpain imaging under two-photon conditions 
By adapting the previously established assay for calpain activity, we 
were able to image calpain activity in the retina under a two-photon 
(2P) microscope. As the calpain assay under apotome investigation is 
in unfixed tissue, this would point to possibilities of performing other 
enzymatic reactions under the 2P. The performance of these live cell 
assays would allow for interaction studies between the causative and 
reaction molecules such as calpain and Ca2+ used here. However, 
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further development and optimisation of the described system above 
is needed. While we have shown that the calpain activity assay under 
the 2P is viable in principle further optimisation of assay conditions 
is needed. The most obvious optimisation is the use of tighter light 
filters with narrow band pass ranges. This would prevent any bleed 
through of the calpain fluorescence into the ECFP channel ensuring 
that Ca2+ dynamics within the cell, alongside calpain activity, could 
be measured accurately. The osmolarity of the combined HEPES 
buffer with the ACSF is far too saline. The levels of potassium in 
particular are approximately 30 times higher than in ACSF alone. 
This is obviously an issue as the continuation of photo transduction 
requires strict ionic balance within the cell. The high level of 
potassium, is likely to affect the activity of NCKX in OS, possibly 
causing an artifactual reduction of OS Ca2+ levels. It is worth testing 
then, if an ACSF based solution with lower potassium levels would 
allow the detection of calpain activity in the ex vivo condition. This 
might require the addition of HEPES for further pH buffering.  
The current system has two main limiting factors, the amount of 
calpain substrate needed per experiment, and the time it takes for a 
cell to die. The amount of the calpain substrate that needs to be used 
is prohibitively high and approximately two experiments can be 
performed per unit. Assuming good TN-XL expression in the cones, 
careful preparation and properly calibrated stimulations, this can still 
provide a wealth of data especially as a proof of concept for other live 
cell assays. Another limiting factor is the incubation time and tissue 
viability period. Currently the incubation of two hours in the water 
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bath accounts for a full one-third of the total tissue viability time. For 
the examination of cell death within the cell and the Ca2+ to calpain to 
cell death link, this time-window may be far too narrow. Ideally, one 
would treat the tissue within the imaging chamber with the calpain 
activity assay as soon as the slice was mounted, but this would 
dramatically increase the levels of substrate needed to maintain assay 
substrate concentration at the necessary levels.  
As said above, the imaging of calpain under 2P conditions has its own 
value and is the first small step towards possible future clinical tests 
that could be performed by injecting a substrate into a patient and 
safely noting its fluorescence in the eye. As patients generally present 
to clinics after the onset of degeneration and as it is difficult to 
diagnose diseases before the onset of the degeneration, markers which 
allow for earlier diagnosis are in demand. For our study of cell death 
derived from Ca2+ dysfunction however, it is of limited use. This is 
again due to the tissue viability time frame of approximately six 
hours, while the time from the initiation of cell death to the execution 
of the cell is many multiples of this. The heterogenic nature of the PR 
cell death in RP and achromatopsia contributes to this limitation, 
especially in the cpfl1 mouse model. The fact that in the cpfl1 mouse 
only cones are degenerating implies that the chance of finding a 
stressed cone in the correct time window is 20-times when compared 
to rod degeneration. This fact alone complicates studies into cone 
Ca2+ dynamics and calpain activity. A fluorescent rod mouse model 
would provide its own challenges and the overlap of cells within the 
retina would cause an overlap of signal which would be a substantial 
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hurdle to overcome. A stimulation protocol that could elicit the 
closure of the Ca2+ channels within rods would also have to be 
devised. There is, however, a method to overcome the heterogenic 
nature of the PR cell death and to allow a more thorough investigation 
of Ca2+, calpain, and cell death interaction. The lab of Dr. Enrica 
Strettoi in Pisa, Italy has Tvrm4 mice, developed by Budzynski et al., 
(2010) at the Jackson Laboratories, whose retinal degeneration can be 
induced using high light levels in a protocol well established by 
(Budzynski et al., 2010), and further optimized to mimic RP by the 
Strettoi lab (Gargini, Novelli, Piano, Biagioni, & Strettoi, 2017). A 
Tvrm4xHR2.1:TN-XL mouse would allow the investigator to control 
the time of the onset of degeneration and to image Ca2+ dynamics 
within cones in this period. A pattern of cell death has been 
established by Antonia Stefanov, a PhD student in Dr Strettoi’s group, 
which allows the investigator to examine certain areas in the retina 
with very precise knowledge of the stage of progression of the 
degeneration. As this Tvrm4 mouse is a rhodopsin mutant model, and 
not a PDE6 mutant model the role of Ca2+ would be diminished as the 
mutation would not be directly linked to Ca2+ regulation, but this does 
point to a possible way to overcome the heterogeneous cell death 
pattern seen in RP and achromatopsia retinas. A model of Pde6c 
mutation in which the degeneration could be induced by the 
investigator, resulting in rapid uniform death in cones would 
overcome all the above obstacles, albeit highly labour intensive. 
Inducing the degeneration is key: there is no known reason why cells 
degenerate when they do, though many think it is in the same order at 
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which they form and mature (Noell, 1958). This leads to the 
inhomogeneous nature of the cell death patterns incorporating events 
such as order of birth, and light levels seen by each mouse while in 
the animal house. Control over inducing the degeneration allows the 
experimenter to induce the degeneration in any number of mice 
simultaneously or separately and record a detailed account of protein 
up-regulation, down-regulation, activation or suppression. This can 
then be combined with RNAseq analysis or any other molecular 
examination into the internal cellular environment, which can be as 
granular or fine as the experimenter would like.  
Future Directions 
Continuation of this study, aside from the thoughts on calpain 
imaging under the 2P above, centre around the further elucidation of 
calpain’s functionality. An investigation into an increase in other 
calpain isoforms would be useful to ensure it is indeed calpain-2 
which is the harmful isoform. More stringent investigations into the 
functionality of calpain-2 would also be useful. Of the four peptides 
stained for with antibodies, only calpain-2 was upregulated in the rd1 
before P24. The lack of caspase-3 or AIF suggests the mode of cell 
death is driven by neither of these and is unlikely to be apoptotic. 
Where the calpain-2 is acting as an activator protein, previous work 
demonstrates a preferred cleavage sequence of the active site, which 
would allow for bioinformatics investigations of known pro-enzymes 
within the cell to yield a list of suspects to act as mediators between 
calpain-2 and cell death. Modelling here presented has provided the 
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greatest indication of marker activity provided so far by the field at 
large. The use of a model with a synchronized onset of retinal 
degeneration would allow for greater understanding of the sequence 
of marker activity we measured here.  
 
Concluding remarks 
Here, we show that Ca2+ dysregulation resulting from Pde6 mutations 
results in increased calpain activity and increased activation of 
calpain-2. Due to the high [Ca2+] needed for calpain-2 activation we 
can surmise that this dysregulation results in increases [Ca2+] in the 
diseased PRs. Our data suggests that primary rod cell death is non-
apoptotic but secondary cone cell death is apoptotic. AIF truncation 
and activation levels between rd1 and rd10 in our data sets suggest 
different cell death mechanism in these models. We show that 
markers for [Ca2+] dysregulation overlap with those for cell death 
spatially and temporally in the rd1 and rd10 mouse models. Our data 
indicates that L-cis diltiazem alters the cones response to light more 
effectively than the D-cis enantiomer. Our modelling suggests 
possible order of marker involvement in the PR degeneration in rd1, 
cpfl1, and wt but not to strongly in rd10. We also provide a proof of 
concept that calpain activity can be imaged under a 2P microscope 
though optimisation is needed.  
Moving forward this work points to Ca2+ and calpain-2 as two targets 
for pharmacological intervention for people with RDs caused by 
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PDE6 mutations. We point to caspase inhibitors as potential therapies 
for the survival of cones in patients with RP. We propose that 
blocking VGCCS and not CNGCS decreases calpain activity in the 
PRs and does not diminish cone responsiveness. Finally, we propose 
that live imaging of protein activity can be achieved in retinal slices 
under the 2P microscope.  
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